var title_f12_0_12288="Finger toad splint";
var content_f12_0_12288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Finger toad splint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12288=[""].join("\n");
var outline_f12_0_12288=null;
var title_f12_0_12289="TTTS8";
var content_f12_0_12289=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    TTTS8",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal cervical length indicating a short cervix of 1.15 cm due to extreme polyhydramnios&nbsp;at approximately 21.5&nbsp;weeks of gestation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kenneth J Moise, Jr, MD &amp; Anthony Johnson, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12289=[""].join("\n");
var outline_f12_0_12289=null;
var title_f12_0_12290="Pathophysiology VSD";
var content_f12_0_12290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Pathophysiology of ventricular septal defect",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 446px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12290=[""].join("\n");
var outline_f12_0_12290=null;
var title_f12_0_12291="Echinococcal cyst series";
var content_f12_0_12291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hepatic echinococcal cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: ERCP demonstrating external compression of the hepatic duct by the cyst. Panel B: CT scan shows a complex septated cyst and a heavily calcified daughter-cyst in the right hepatic lobe (arrowhead), in a 38-year old man. Panel C: Post resection. Panel D: Histologic appearance of a degenerated cyst containing fragments of the germinal membrane (hematoxylin and eosin, original magnification: x 2000).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Regev, A, Reddy, KR, Berho, M, et al. Large cystic lesions of the liver in adults: A 15-year experience in a tertiary center. J Am Coll Surg 2001; 193:36. Copyright &copy; 2001 American College of Surgeons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12291=[""].join("\n");
var outline_f12_0_12291=null;
var title_f12_0_12292="Comedo ductal carcinoma in situ";
var content_f12_0_12292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F77048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F77048&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Comedo ductal carcinoma in situ",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light microscopic specimen of comedo ductal carcinoma in situ shows a large central area of necrosis that is focally calcified. The nuclei are poorly differentiated (high grade).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stuart Schnitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12292=[""].join("\n");
var outline_f12_0_12292=null;
var title_f12_0_12293="Bexarotene (topical): Patient drug information";
var content_f12_0_12293=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bexarotene (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28916?source=see_link\">",
"     see \"Bexarotene (topical): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7995774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Targretin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lymphoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701624",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bexarotene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696926",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use gel with insect repellents that have N, N-diethyl-m-toluamide (DEET).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698524",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), you will need to watch your blood sugar closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol or are taking a cholesterol-lowering drug, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697767",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use 2 kinds of birth control that you can trust 1 month before care begins, during care, and for at least 1 month after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use 2 kinds of birth control that you can trust 1 month before care begins, during care, and for at least 1 month after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug or within 1 month after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For men, if your woman partner gets pregnant while you are being treated or within 1 month after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694533",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid putting on healthy skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let gel dry before covering with clothing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wait 20 minutes after bathing before putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694697",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover with dressings.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698520",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a woman of childbearing age, take a pregnancy test 1 week before you start therapy and monthly while using this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11433 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-0D12DA5E94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12293=[""].join("\n");
var outline_f12_0_12293=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7995774\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026847\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026849\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026848\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026853\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026854\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026856\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026851\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026852\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026857\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026858\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/11/28854?source=related_link\">",
"      Bexarotene (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/14/36069?source=related_link\">",
"      Bexarotene (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/15/28916?source=related_link\">",
"      Bexarotene (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_0_12294="ASPECTS study form";
var content_f12_0_12294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F72190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F72190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    ASPECTS study form",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ASPECTS value is calculated from two standard axial CT cuts: one at the level of the thalamus and basal ganglia (left), and one just rostral to the basal ganglia (right). A: anterior circulation; P: posterior circulation; C: caudate; L: lentiform; IC: internal capsule; I: insular ribbon; MCA: middle cerebral artery; M1: anterior MCA cortex; M2: MCA cortex lateral to insular ribbon; M3: posterior MCA cortex; M4, M5, and M6 are anterior, lateral, and posterior MCA territories immediately superior to M1, M2, and M3, rostral to basal ganglia",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Barber, PA, Demchuk, AM, Zhang, J, Buchan, AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355:1670. Copyright &copy; 2000 The Lancet.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12294=[""].join("\n");
var outline_f12_0_12294=null;
var title_f12_0_12295="Treatment and complications of persistent hyperinsulinemic hypoglycemia of infancy";
var content_f12_0_12295=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment and complications of persistent hyperinsulinemic hypoglycemia of infancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Agneta Sunehag, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Morey W Haymond, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12295/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/0/12295/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent hyperinsulinemic hypoglycemia of infancy (PHHI), previously called familial hyperinsulinism, congenital hyperinsulinemia, and primary islet cell hypertrophy (nesidioblastosis), is the most common cause of persistent hypoglycemia in infancy. PHHI is a genetic disorder with familial and sporadic forms, both of which are characterized by dysregulation of insulin secretion. Early recognition, diagnosis, and treatment are necessary to prevent or minimize neurologic damage from recurrent or prolonged episodes of hypoglycemia.",
"   </p>",
"   <p>",
"    PHHI is a clinically and genetically heterogeneous disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The clinical manifestations range from life-threatening hypoglycemia presenting on the first day of life to only mildly symptomatic hypoglycemia in a child or adolescent that may be difficult to identify. The response to medical and surgical therapy also varies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment and complications of PHHI will be presented here. The pathology, genetics, clinical features, and diagnosis of PHHI and a review on islet cell tumors (insulinomas), which have similar clinical and biochemical features to PPHI, are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3866?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=see_link\">",
"     \"Insulinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT GOALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goal of therapy in persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is the prevention of acute neurologic symptoms (eg, seizure, lethargy, coma) and long-term sequelae (eg, epilepsy, mental retardation, microcephaly) of prolonged",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    recurrent hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The immediate goal is normalization of the plasma glucose concentration via intravenous administration of glucose",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      enteral feeding.",
"     </li>",
"     <li>",
"      Long-term therapeutic approaches are directed toward decreasing insulin secretion pharmacologically or surgically and maintaining euglycemia to protect neurologic function.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapy in infants and children with PHHI always should be directed by, or in conjunction with, a pediatric endocrinologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     HYPOGLYCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attempts must be made to maintain plasma glucose within the normal range during the diagnostic process (except during the controlled diagnostic \"fast\").",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31924479\">",
"    <span class=\"h2\">",
"     Intravenous therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral glucose usually is required to maintain the plasma glucose concentrations in a normal range (80 to 130",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    or 4.4 to 7.0 mM). In addition, placement of a central line should be considered early in the diagnostic and stabilization phase of management, because high rates of glucose infusion (10 to 40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per min) and high glucose concentration in the infusate (&gt;10 percent) may be required to maintain euglycemia. We recommend measuring the blood glucose concentration at 30 to 60 minute intervals until a stable blood glucose concentration is established within the normal range. Once euglycemia is established, monitoring frequency should be decreased to an appropriate interval to assure maintenance of a normal plasma glucose concentration. &nbsp;",
"   </p>",
"   <p>",
"    Intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/0/37891?source=see_link\">",
"     glucagon",
"    </a>",
"    (1 to 10",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per hour, as a continuous infusion) may be helpful during the initial stabilization period and before surgery. However, this treatment has not been of long-term benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dietary therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary therapy consisting of frequent and consistent feedings in infants may be helpful to reduce the frequency and severity of hypoglycemic episodes and reduce the need for intravenous glucose. In some older infants and children with mild disease, frequent high-carbohydrate meals and the ingestion of uncooked cornstarch at night may be sufficient to maintain normal blood glucose concentrations without intravenous administration of glucose [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. However, this technique may not be effective in young infants who may be relatively deficient in amylase. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HYPERINSULINEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term therapeutic approaches for persistent hyperinsulinemic hypoglycemia of infancy (PHHI) are directed toward decreasing insulin secretion. This may be accomplished pharmacologically or surgically. Pharmacologic interventions, although frequently unsuccessful, always should be tried before surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacologic therapy for hyperinsulinism may involve treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"     diazoxide",
"    </a>",
"    (a specific ATP-dependent potassium [KATP] channel agonist in normal beta cells), somatostatin analogues (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    ), or calcium channel blockers (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/2/9256?source=see_link\">",
"     nifedipine",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31077305\">",
"    <span class=\"h3\">",
"     Diazoxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"     Diazoxide",
"    </a>",
"    is the first-line therapy. It works by blocking the sulfonylurea receptors on the beta cells, resulting in opening of the KATP channels, and decreasing insulin release. Diazoxide is administered in doses of 5 to 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided into three doses. The initial dose varies depending upon the preference of the treating provider. Some start with 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day and increase the dose as necessary; others start with 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day and decrease the dose as tolerated.",
"   </p>",
"   <p>",
"    Regardless of approach, it has been our experience that if a child does not respond at 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, he or she will not respond at &ge;20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, and increasing the dose only increases the risks of medication-related complications. Defining a clear clinical response in this situation frequently is difficult. If no clear response is observed within 48 hours of the initiation of a dose,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"     diazoxide",
"    </a>",
"    will probably not be effective, and other alternatives should be considered. The authors define treatment success as maintenance of euglycemia after an overnight fast of 14 to 16 hours.",
"   </p>",
"   <p>",
"    The most common side effects include hypertrichosis and sodium and water retention. Other side effects include advanced bone age, mild hyperuricemia, decreased IgG concentration, and decreased neutrophil counts. Water retention can be reduced by a thiazide diuretic, which may further reduce insulin secretion (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/27/20919?source=see_link\">",
"     chlorothiazide",
"    </a>",
"    7 to 10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided into two doses). Life-threatening complications such as ketoacidosis, heart failure, and nonketotic hyperosmolar coma are rare and can be avoided by daily monitoring of plasma glucose, urinary ketones, and fluid balance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31077312\">",
"    <span class=\"h3\">",
"     Somatostatin analogues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatostatin analogues (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    ) can be tried as a second-line therapy to reduce insulin secretion if treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"     diazoxide",
"    </a>",
"    is unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/6\">",
"     6",
"    </a>",
"    ]. It is frequently started with the diazoxide in an attempt to obtain control of the plasma glucose concentration.",
"   </p>",
"   <p>",
"    The dose of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    is 5 to 20",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day divided into three doses, but even higher doses have been used. The authors initiate therapy at 5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per injection, giving one to two injections per day, and double the dose if the patient remains hypoglycemic. No clear maximum dose has been established for these children. In some instances, 100 to 200",
"    <span class=\"nowrap\">",
"     mcg/hour",
"    </span>",
"    has been used for short periods of time to determine the potential for therapeutic efficacy. The anticipated response under these circumstances is an acute rise in the plasma glucose concentration. Long-term follow-up studies have not been carried out to assess the potential side effects of prolonged therapy with octreotide for hyperinsulinism. Linear growth should be observed closely, as octreotide suppresses growth hormone secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two studies report the use of two different long-acting somatostatin analogues in children with PHHI with a variety of genotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In both reports it had been established that these children were responsive to short-acting somatostatin. After switching to long-acting release",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/6/37991?source=see_link\">",
"     octreotide",
"    </a>",
"    (Sandostatin LP&reg;, Novartis) delivered IM monthly, glycemic control was slightly worse [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/8\">",
"     8",
"    </a>",
"    ]. The treatment seemed to be well tolerated despite requiring local anesthesia and sedation for each injection. Reported quality of life was unchanged for the children, but the parents&rsquo; reports of general satisfaction were improved because of fewer injections and less concern about missed or delayed injections [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, these long-acting compounds may be useful in children who can be managed on a somatostatin analog, but should probably not be used as the first line medication until more thorough studies have been conducted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31077319\">",
"    <span class=\"h3\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium channel blockers (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/2/9256?source=see_link\">",
"     nifedipine",
"    </a>",
"    ) are another alternative therapy. The use of nifedipine at doses of 0.5 to 2.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day has been reported to be successful in controlling insulin secretion or reducing the doses of other agents [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. The use of calcium-channel blocking agents for PHHI has not been evaluated in controlled trials. In the absence of such a trial, and because calcium-channel blocking agents have been used in conjunction with other medications and feeding strategies, their therapeutic efficacy, if any, remains to be determined. Long-term follow-up studies have not been carried out to assess the potential side effects of prolonged therapy with calcium-channel blockers for hyperinsulinism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31077326\">",
"    <span class=\"h3\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, PHHI is a heterogeneous disorder, with heterogeneous response to therapy. It is reported that pharmacologic therapy is most useful in patients with autosomal dominant PHHI [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/14\">",
"     14",
"    </a>",
"    ]. Some infants with the autosomal recessive form of PHHI respond to pharmacologic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/15\">",
"     15",
"    </a>",
"    ], but most do not [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/14\">",
"     14",
"    </a>",
"    ]. Pharmacologic and dietary therapy are more often successful in patients who present in infancy or childhood rather than as neonates (69 percent versus 29 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3866?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants and children with PHHI who are successfully treated pharmacologically should monitor blood glucose at home, particularly during intercurrent illnesses and fasts longer than 14 to 16 hours. Because there are case reports of spontaneous regression of PHHI [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/16\">",
"     16",
"    </a>",
"    ], patients should be reevaluated after four to six years of treatment to determine whether there is a need for continued treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Surgical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical exploration is warranted in children older than several weeks of age in whom hyperinsulinism is proven and pharmacologic therapy fails to control hypoglycemia. However, caution should be used when considering an aggressive surgical approach within days of diagnosis. In some children, it is nearly impossible to maintain the plasma glucose concentration within a safe range regardless of medical management (medication and oral and intravenous glucose), and surgical management must be considered. On the other hand early surgical intervention may not be appropriate for other infants, such as infants exposed to perinatal stress (eg, birth asphyxia, prematurity, intrauterine growth retardation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maternal toxemia). This group of infants is generally responsive to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"     diazoxide",
"    </a>",
"    , and the hyperinsulinemia resolves within days to months but nearly always within six months. The etiology for the dysregulation of insulin secretion in these patients remains to be elucidated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/17-19\">",
"     17-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Focal lesions, even those that have been localized before surgery, are often difficult to find in the pancreas during surgery. Some investigators have used intraoperative ultrasonography to identify focal lesions successfully [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/20\">",
"     20",
"    </a>",
"    ]. 18-F-DOPA PET CT scan has shown promising results in accurately identifying focal lesions. The detection limit is 10",
"    <sup>",
"     5",
"    </sup>",
"    to 10",
"    <sup>",
"     6",
"    </sup>",
"    cells or a diameter of 1 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/21\">",
"     21",
"    </a>",
"    ]. Unfortunately, this modality is only available in a limited number of institutions around the world and will reduce the number of near total pancreatectomies in infant with adenomas since a number of these children with adenomas in the head of the pancreas may require significant resection of the pancreas. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    When a focal lesion is identified, it can usually, but not always, be excised, leaving the remainder of the pancreas intact. A series of samples should be obtained from what is believed to be unaffected pancreas for histopathologic examination to determine whether the child has focal or diffuse disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/22\">",
"     22",
"    </a>",
"    ]. Frozen section in focal disease shows beta cell crowding with small nuclei, whereas frozen section in diffuse disease shows diffuse hyperplasia of beta cells with giant nuclei [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/23\">",
"     23",
"    </a>",
"    ]. Such frozen section diagnoses are much more difficult and require an experienced pathologist. If focal disease is detected, the lesion(s) should be identified and resected [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Selective resection of focal anomalies is often curative, whereas diffuse disease requires subtotal pancreatectomy, in which 95 to 99 percent of the pancreas is removed. Several reports have been published on the successful use of laparoscopic surgery for diagnosing and removal of focal lesions as well as for near total pancreatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/27-31\">",
"     27-31",
"    </a>",
"    ]. This approach has several advantages compared with open surgery: it can be performed at an earlier postnatal age; the patient can be back on oral feedings within a day after surgery; and it is associated with minimal bleeding.",
"   </p>",
"   <p>",
"    Surgical outcome depends upon islet cell pathology, location of lesion(s), the underlying mechanism for abnormal insulin secretion, and extent of pancreatectomy. Exogenous insulin may be required to control hyperglycemia for several weeks to months after subtotal pancreatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/3\">",
"     3",
"    </a>",
"    ]. On the other hand, recurrence of hypoglycemia within 24 to 48 hours of surgery indicates that control of glucose homeostasis will most likely continue to be difficult and additional surgery may be necessary. The range of outcomes is illustrated by a series of 105 neonates and infants with congenital hyperinsulinism who underwent near-total or partial pancreatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 58 patients with diffuse disease treated with near-total pancreatectomy, 59 percent had mild or asymptomatic hypoglycemia that responded to medical management and needed no further surgical treatment for hypoglycemia within five years. Ten patients underwent a second surgery because of persistent hypoglycemia. Hyperglycemia was common initially (53 percent), and became universal within 13 years, usually requiring insulin therapy. &nbsp;",
"     </li>",
"     <li>",
"      Among 47 patients with focal disease, treated with partial pancreatectomy, hypoglycemia and hyperglycemia were rare, mild and transient. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Careful follow-up of each patient is necessary to monitor long-term effects of subtotal pancreatectomy on pancreatic function. Exocrine function is usually sufficient for normal fat absorption. On the other hand, subtotal pancreatectomy carries with it a high risk for the future development of diabetes mellitus and malabsorption. If hypoglycemia recurs after surgery, reexploration with near-total pancreatectomy should be pursued in conjunction with pharmacologic therapy as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic sequelae, including psychomotor retardation, cognitive deficits (in short-term memory, visuomotor integration, and arithmetic skills), and epilepsy may result from repeated or prolonged episodes of hypoglycemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one retrospective study of 90 children with persistent hyperinsulinemic hypoglycemia of infancy (PHHI) who were diagnosed as neonates or infants, 19 patients (21 percent) had severe or intermediate psychomotor retardation, 16 (18 percent) had epilepsy, and 17 percent had microcephaly [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/1\">",
"       1",
"      </a>",
"      ]. Neurologic sequelae were more common among patients diagnosed as neonates, but there was no difference between focal and diffuse forms.",
"     </li>",
"     <li>",
"      In another review of 114 patients, 44 percent of patients had psychomotor or mental retardation and 25 percent developed epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/3\">",
"       3",
"      </a>",
"      ]. Unfavorable outcomes were more common among patients with onset in infancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is the most common cause of persistent hypoglycemia in infancy. PHHI is a genetic disorder with familial and sporadic forms, both of which are characterized by dysregulation of insulin secretion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary goal of therapy in PHHI is the prevention of neurologic symptoms and sequelae (eg, epilepsy, mental retardation, microcephaly) of prolonged",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent hypoglycemia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment goals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The first management priority is restoration of normal plasma glucose via administration of parenteral glucose and frequent oral feedings, as appropriate. Because high rates of infusion and high concentrations of glucose may be required to avoid fluid overload, the placement of a central line should be considered early in the evaluation of such children. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Hypoglycemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As the plasma glucose concentration is being stabilized, pharmacologic therapy with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/11/13492?source=see_link\">",
"       diazoxide",
"      </a>",
"      and frequent oral feedings (if tolerated) should begin. Second-line pharmacologic agents (somatostatin analogues, calcium channel blockers) should be added as necessary. Pharmacologic therapy is most likely to be successful in patients who present beyond the neonatal period, or in those with autosomal dominant PHHI. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who can maintain normal plasma glucose concentrations with frequent feedings and pharmacologic agents should be able to tolerate an overnight fast (14 hours) without developing hypoglycemia before discharge from the hospital [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12295/abstract/33\">",
"       33",
"      </a>",
"      ]. Once discharged, blood glucose must be monitored at home, particularly during intercurrent illnesses; fasts of longer than 14 hours should be avoided depending upon the tolerance of the individual child. (See",
"      <a class=\"local\" href=\"#H31077326\">",
"       'Follow-up'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Partial pancreatectomy can be attempted in patients who appear to have focal disease. Multiple biopsies should be taken from apparently unaffected areas of the pancreas to exclude diffuse disease. Subtotal or near total pancreatectomy should be planned for patients with diffuse disease whose hypoglycemia can only be managed with pharmacologic agents and continuous IV glucose. Patients undergoing near-total pancreatectomy generally require transient exogenous insulin therapy in the postoperative period and a significant number develop permanent diabetes mellitus within a decade after the surgery. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PHHI may cause neurologic sequelae such as psychomotor retardation, cognitive deficits (in short-term memory, visuomotor integration, and arithmetic skills), and epilepsy. These complications may be caused by repeated or prolonged episodes of hypoglycemia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/1\">",
"      Menni F, de Lonlay P, Sevin C, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001; 107:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/2\">",
"      Bruining GJ. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990; 2:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/3\">",
"      Meissner T, Wendel U, Burgard P, et al. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003; 149:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/4\">",
"      Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 1993; 123:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/5\">",
"      Ehara A, Takahashi M, Nobumoto K, et al. Successful control of persistent hyperinsulinemic hypoglycemia of infancy with a high dextrin formula. Acta Paediatr Jpn 1998; 40:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/6\">",
"      Thornton PS, Alter CA, Katz LE, et al. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 1993; 123:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/7\">",
"      DeClue TJ, Malone JI, Bercu BB. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr 1990; 116:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/8\">",
"      Le Quan Sang KH, Arnoux JB, Mamoune A, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol 2012; 166:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/9\">",
"      Modan-Moses D, Koren I, Mazor-Aronovitch K, et al. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). J Clin Endocrinol Metab 2011; 96:2312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/10\">",
"      Ba�� F, Darendeliler F, Demirkol D, et al. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab 1999; 12:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/11\">",
"      Eichmann D, Hufnagel M, Quick P, Santer R. Treatment of hyperinsulinaemic hypoglycaemia with nifedipine. Eur J Pediatr 1999; 158:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/12\">",
"      Shanbag P, Pathak A, Vaidya M, Shahid SK. Persistent hyperinsulinemic hypoglycemia of infancy--successful therapy with nifedipine. Indian J Pediatr 2002; 69:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/13\">",
"      Darendeliler F, Fournet JC, Ba�� F, et al. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures. J Pediatr Endocrinol Metab 2002; 15:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/14\">",
"      Thornton PS, Satin-Smith MS, Herold K, et al. Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr 1998; 132:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/15\">",
"      Kane C, Lindley KJ, Johnson PR, et al. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clin Invest 1997; 100:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/16\">",
"      Kubota A, Yonekura T, Usui N, et al. Two cases of persistent hyperinsulinemic hypoglycemia that showed spontaneous regression and maturation of the Langerhans islets. J Pediatr Surg 2000; 35:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/17\">",
"      Hoe FM, Thornton PS, Wanner LA, et al. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr 2006; 148:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/18\">",
"      Clark W, O'Donovan D. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia. Am J Perinatol 2001; 18:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/19\">",
"      Schultz K, Solt&eacute;sz G. Transient hyperinsulinism in asphyxiated newborn infants. Acta Paediatr Hung 1991; 31:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/20\">",
"      Telander RL, Charboneau JW, Haymond MW. Intraoperative ultrasonography of the pancreas in children. J Pediatr Surg 1986; 21:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/21\">",
"      Kapoor RR, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab 2009; 5:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/22\">",
"      Giurgea I, Laborde K, Touati G, et al. Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. J Clin Endocrinol Metab 2004; 89:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/23\">",
"      Sempoux C, Guiot Y, Lefevre A, et al. Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 1998; 83:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/24\">",
"      Cr&eacute;tolle C, F&eacute;k&eacute;t&eacute; CN, Jan D, et al. Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: A report of 45 cases from 1983 to 2000. J Pediatr Surg 2002; 37:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/25\">",
"      Simmons PS, Telander RL, Carney JA, et al. Surgical management of hyperinsulinemic hypoglycemia in children. Arch Surg 1984; 119:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/26\">",
"      Laje P, Stanley CA, Palladino AA, et al. Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg 2012; 47:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/27\">",
"      De Vroede M, Bax NM, Brusgaard K, et al. Laparoscopic diagnosis and cure of hyperinsulinism in two cases of focal adenomatous hyperplasia in infancy. Pediatrics 2004; 114:e520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/28\">",
"      Bax KN, van der Zee DC. The laparoscopic approach toward hyperinsulinism in children. Semin Pediatr Surg 2007; 16:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/29\">",
"      Al-Shanafey S, Habib Z, AlNassar S. Laparoscopic pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Surg 2009; 44:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/30\">",
"      Al-Shanafey S. Laparoscopic vs open pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr Surg 2009; 44:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/31\">",
"      Liem NT, Son TN, Hoan NT. Laparoscopic near-total pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy: report of two cases. J Laparoendosc Adv Surg Tech A 2010; 20:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/32\">",
"      Beltrand J, Caquard M, Arnoux JB, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 2012; 35:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12295/abstract/33\">",
"      Haymond MW. Hypoglycemia in infants and children. Endocrinol Metab Clin North Am 1989; 18:211.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5851 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-A1F0AAE071-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12295=[""].join("\n");
var outline_f12_0_12295=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT GOALS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HYPOGLYCEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31924479\">",
"      Intravenous therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dietary therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HYPERINSULINEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31077305\">",
"      - Diazoxide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31077312\">",
"      - Somatostatin analogues",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31077319\">",
"      - Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31077326\">",
"      - Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Surgical therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=related_link\">",
"      Insulinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/49/3866?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of persistent hyperinsulinemic hypoglycemia of infancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_0_12296="Diagnosis of spontaneous bacterial peritonitis";
var content_f12_0_12296=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of spontaneous bacterial peritonitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12296/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/0/12296/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intraabdominal surgically-treatable source [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/1\">",
"     1",
"    </a>",
"    ]. The presence of SBP, which almost always occurs in patients with cirrhosis and ascites, is suspected because of suggestive signs and symptoms (",
"    <a class=\"graphic graphic_table graphicRef71038 \" href=\"UTD.htm?17/61/18395\">",
"     table 1",
"    </a>",
"    ). The diagnosis is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7172?source=see_link\">",
"     \"Clinical manifestations of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will focus on the major issues involved in establishing the diagnosis of SBP, beginning with the safety of paracentesis. The distinction of SBP from secondary bacterial peritonitis and from alcoholic hepatitis in patients with or without cirrhosis and ascites will also be discussed.",
"   </p>",
"   <p>",
"    The treatment and prophylaxis of SBP is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .) The AASLD guideline for the management of adult patients with ascites due to cirrhosis (updated in 2009) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/2\">",
"     2",
"    </a>",
"    ], as well as other AASLD guidelines, can be accessed through the AASLD web site at",
"    <a class=\"external\" href=\"file://www.aasld.org/practiceguidelines/Pages/default.aspx\">",
"     www.aasld.org/practiceguidelines/Pages/default.aspx",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SAFETY OF PARACENTESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The criteria for the diagnosis of SBP require that abdominal paracentesis be performed and ascitic fluid be analyzed before a diagnosis of SBP can be made. A \"clinical diagnosis\" of SBP without paracentesis is not adequate.",
"   </p>",
"   <p>",
"    Many clinicians inappropriately avoid performing minor procedures on patients with ascites because of coagulopathy and fear of hemorrhagic complications. Approximately 70 percent of patients with ascites have an abnormal prothrombin time [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/3\">",
"     3",
"    </a>",
"    ]. However, the fear of hemorrhagic complications is unfounded except in the setting of clinically apparent disseminated intravascular coagulation or clinically apparent fibrinolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/4\">",
"     4",
"    </a>",
"    ]. These conditions occur in fewer than 1 in every 1000 paracenteses.",
"   </p>",
"   <p>",
"    Furthermore, the number of patients who require transfusion of red blood cells for a paracentesis-related hemorrhage is less than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. In a study involving 1100 large-volume paracenteses, patients tolerated the procedure without transfusions (of any type before or after paracentesis) despite an INR as high as 8.7 and platelet count as low as 19,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, the benefits of diagnostic paracentesis outweigh the risks in almost all circumstances. The general indications for abdominal paracentesis are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef64189 \" href=\"UTD.htm?21/0/21515\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The liver makes most procoagulants as well as most endogenous anticoagulants [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/6\">",
"     6",
"    </a>",
"    ]. The prothrombin",
"    <span class=\"nowrap\">",
"     time/INR",
"    </span>",
"    only measures the deficiency of procoagulants and is currently based on controls who are taking coumadin rather than controls with cirrhosis. Thus, the commercially available coagulation tests including the PT, aPTT, and INR do not necessarily reflect the coagulation status in patients with cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24022?source=see_link\">",
"     \"Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some clinicians transfuse plasma or platelets prior to paracentesis in patients with coagulopathy. This practice is not supported by data and would lead to transfusion of approximately 140 units of plasma to prevent transfusion of only two units of red cells [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/3,5,7\">",
"     3,5,7",
"    </a>",
"    ]. We have never given prophylactic plasma or platelets prior to abdominal paracentesis in the thousands of procedures that we have performed.",
"   </p>",
"   <p>",
"    A prospective study demonstrated that the abdominal wall is thinner and the pool of fluid is deeper in the left lower quadrant compared to the midline [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/8\">",
"     8",
"    </a>",
"    ]. The high prevalence of obesity (with a thick panniculus) the more frequent need for therapeutic paracentesis compared to diagnostic paracentesis make a tap site 3 cm cephalad and 3 cm medial to the anterior superior iliac spine preferable to the midline [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Traumatic paracentesis occurs when the bowel is entered by the paracentesis needle. This complication is recognized when air, enteric fluid, or frank stool is aspirated during attempted paracentesis. It usually occurs when the operator is inexperienced, the needle is placed too close to a surgical scar (with bowel adherent to the abdominal wall), or ileus is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ASCITIC FLUID ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediately after the paracentesis needle and attached syringe are withdrawn from the abdomen, the \"skin\" needle should be removed and replaced with a sterile needle to minimize the risk of skin flora growing in the cultures. Appropriate handling of the ascitic fluid that is aspirated is essential to optimize the results [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/7\">",
"     7",
"    </a>",
"    ]. Otherwise, a negative culture may be obtained, possibly leading to the diagnosis of culture negative neutrocytic ascites. Alternatively, careless handling can lead to a skin contaminant growing in the culture bottles, a false-positive culture. Most patients with culture negative neutrocytic ascites actually have SBP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40292?source=see_link\">",
"     \"Spontaneous bacterial peritonitis variants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Handling of the ascitic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Handling of the ascitic fluid sample should include the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appropriately prepared blood culture bottles should be inoculated preferably with at least 10 mL of fluid. However, some bottles will not permit more than the recommended amount of fluid to be instilled without infringing upon the \"head space\" in the bottle in which case the upper end of the recommended amount of fluid should be instilled. These bottles should be sent for bacterial culture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both the use of blood culture bottles and the volume of the sample are important. Sending a syringe or tube of fluid to the laboratory for culture dramatically decreases the sensitivity of the results since SBP is a low-colony-count monomicrobial infection similar to bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/7,9,10\">",
"     7,9,10",
"    </a>",
"    ]. Culturing ascitic fluid as if it were blood (with bedside inoculation of ascitic fluid into blood culture bottles) has been shown to increase the culture-positivity of the ascitic fluid of patients with an ascitic fluid PMN count &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    (in the absence of prior antibiotic treatment, pancreatitis, tuberculous peritonitis, or malignancy-related ascites) from about 50 to 77 (with delayed inoculation) to 80 to 100 percent with immediate inoculation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/1,9,10\">",
"     1,9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The volume of fluid cultured also has a dramatic impact on the sensitivity of the culture in detecting bacterial growth. In one report, for example, inoculation of 10 or 20 mL of fluid into 100 mL blood culture bottles led to a much higher culture-positivity rate than a 1 mL inoculum (93 versus 53 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 1 mL of fluid should be injected into a \"purple-top\" EDTA tube for cell count. An accurate cell count cannot be obtained if the fluid is allowed to clot or submitted in a nonanticoagulated tube.",
"     </li>",
"     <li>",
"      Several mL of fluid should be injected into a \"red-top\" tube for chemistries. Chemistries should include albumin, so that the serum-ascites albumin gradient can be determined, total protein concentration, glucose, lactate dehydrogenase, and amylase. If the fluid is dark orange or brown, a bilirubin concentration should be obtained.",
"     </li>",
"     <li>",
"      A separate syringe or tube of fluid should be sent for Gram stain. The latter test will not be performed if a separate sample of fluid is not submitted with the request for Gram stain. Laboratories will not perform a Gram stain on the culture bottles until they have incubated for 12 to 24 hours. Centrifugation of the fluid prior to performing a Gram stain is not necessary since it does not increase the yield and may actually decrease the likelihood of obtaining a positive culture [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/7\">",
"       7",
"      </a>",
"      ]. Gram stain is notoriously insensitive in detecting SBP and is associated with a high false positive rate [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/7\">",
"       7",
"      </a>",
"      ]. One study found that 16 of 31 positive Gram stains were false positives and that only 1 Gram stain out of 796 led to a change in antibiotic treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cell count",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of the ascitic fluid consists of routine, optional, and unusual tests (",
"    <a class=\"graphic graphic_table graphicRef62032 \" href=\"UTD.htm?30/11/30907\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The cell count and differential should be ordered \"stat\", otherwise many laboratories will prioritize the cell count below routine peripheral blood counts. The absolute PMN count in the ascitic fluid is calculated by multiplying the total white blood cell count (or total \"nucleated cell\" count) by the percentage of PMNs in the differential. The diagnosis of SBP is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3).",
"    </span>",
"   </p>",
"   <p>",
"    If the lab provides an \"expanded differential\" including bands or even earlier forms of PMNs, these should be added together as PMNs and that percentage should be multiplied by the total cell count to obtain the absolute PMN count. The cell count and differential are performed manually (meaning that a technician must be removed from other duties to perform the count) without formal quality control. Thus, the accuracy of these tests is totally dependent upon the skill and interest of the medical technologist. Some investigators believe that automated cell counts can be accurate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/12\">",
"     12",
"    </a>",
"    ]. This has not been our experience; we have found that their accuracy is poor at low PMN count. Nevertheless, the automated approach has the potential to improve the speed with which results are obtained if it can be validated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One potential source of error in the PMN count is that hemorrhage into the ascitic fluid, as in a traumatic paracentesis, leads to red cell and white cell entry into the fluid. A corrected PMN count should be calculated if there is bloody fluid: one PMN is subtracted from the absolute PMN count for every 250 red",
"    <span class=\"nowrap\">",
"     cells/mm3.",
"    </span>",
"    PMNs lyse rapidly, much more so than red cells. Thus, if the bleeding episode occurred prior to rather than during paracentesis, the PMNs that entered the fluid may have lysed and the corrected PMN count may be a negative number.",
"   </p>",
"   <p>",
"    The results should be available in one to four hours. Delayed results lead to delayed detection of infection, delayed initiation of empiric treatment, and decreased chance for survival of the patient. The results of the cell count should be reviewed and a decision made about treatment within a few hours of the paracentesis. It is prudent to write the initial antibiotic order to be given \"stat\" to prevent an inadvertent delay in administration of the first dose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .) Use of dipsticks could provide presumptive evidence of SBP in 90 to120 seconds (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Dipstick tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The cell count, Gram stain, and culture provide the necessary information to make the diagnosis of SBP in most patients. In selected cases, however, one or more of the following tests may be useful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Serum-ascites albumin gradient",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum-ascites albumin gradient indirectly measures portal pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The albumin concentration of ascitic fluid and serum must be obtained on the same day. The ascitic fluid value is",
"    <strong>",
"     subtracted",
"    </strong>",
"    from the serum value to obtain the gradient (",
"    <a class=\"graphic graphic_table graphicRef81696 \" href=\"UTD.htm?17/56/18315\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the difference (",
"      <strong>",
"       not a ratio",
"      </strong>",
"      ) is &gt;1.1",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      the patient has portal hypertension, with 97 percent accuracy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If the difference is &lt;1.1",
"      <span class=\"nowrap\">",
"       g/dL,",
"      </span>",
"      portal hypertension is not present [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The vast majority of patients with SBP have portal hypertension secondary to cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=see_link\">",
"     \"Pathogenesis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .) Patients with a serum-ascites albumin gradient below 1.1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (ie, without portal hypertension) rarely develop SBP. An exception may occur in patients with the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ascitic fluid total protein concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of the ascitic fluid total protein concentration assists in separating SBP from secondary bacterial peritonitis. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Distinction of spontaneous from secondary bacterial peritonitis'",
"    </a>",
"    below.) It correlates",
"    <strong>",
"     inversely",
"    </strong>",
"    with the risk of developing SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/17\">",
"     17",
"    </a>",
"    ]. Patients with the most dilute ascites (ie, protein concentration less than 1",
"    <span class=\"nowrap\">",
"     gm/dL)",
"    </span>",
"    have the lowest concentration of opsonins in the ascitic fluid and are at the highest risk for SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The total protein concentration does not change during an episode of SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ascitic fluid glucose concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophils can consume large quantities of glucose. Thus, the concentration of PMNs in ascitic fluid and their degree of stimulation correlate inversely, in a general way, with the glucose concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"     19",
"    </a>",
"    ]. The glucose concentration generally remains above 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in SBP, but frequently falls below this level in secondary bacterial peritonitis; with gut perforation, the ascitic fluid glucose concentration may fall to near zero [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ascitic fluid lactate dehydrogenase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactate dehydrogenase (LDH) in ascitic fluid is released from PMNs that have lysed. The concentration is increased in SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"     19",
"    </a>",
"    ], and is even further elevated in secondary bacterial peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]. One study, for example, analyzed 22 patients whose ascitic fluid was examined before and then during an episode of SBP. The LDH concentration increased significantly during infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"     19",
"    </a>",
"    ]. The upper limit of normal for LDH varies by laboratory. In sterile ascitic fluid in the setting of cirrhosis, the LDH is generally in the range of 43",
"    <span class=\"nowrap\">",
"     +/-20mU/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ascitic fluid amylase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amylase concentration is increased in ascitic fluid in pancreatitis and gut perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Every segment of the gut, with the exception of the gallbladder, leaks amylase into the fluid when it perforates. In one report, for example, two patients with pancreatic ascites had a mean ascitic fluid amylase concentration of 1957 int.",
"    <span class=\"nowrap\">",
"     unit/L,",
"    </span>",
"    a value more than five times that in the plasma. In contrast, the mean amylase concentration in patients with nonpancreatic ascites was 42 int.",
"    <span class=\"nowrap\">",
"     unit/L,",
"    </span>",
"    a value just under one-half that of serum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ascitic fluid bilirubin concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bilirubin concentration should be measured only if the ascitic fluid is dark orange or brown. If the value is higher than that of serum and greater than 6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    and the ascitic fluid amylase is not elevated (indicating upper intestinal perforation), it can be assumed that the gallbladder has perforated into the peritoneum (choleperitoneum) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/22\">",
"     22",
"    </a>",
"    ]. The ascitic fluid bilirubin concentration in most other causes of ascites averaged 0.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in one report; this value was approximately one-third that in the plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the late 1980s and early 1990s, numerous papers were published that purported to show the utility of ascitic fluid pH, lactate, and other difficult-to-measure indirect markers of infection. Subsequent larger scale studies, which used current culture methods and appropriate grouping of patients,",
"    <strong>",
"     failed",
"    </strong>",
"    to confirm the utility of these tests [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Until these and other newer tests are demonstrated to improve outcomes rather than just increasing confusion about their place in the decision tree, they should be viewed as investigational.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dipstick tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing for leukocyte esterase in ascitic fluid with a reagent strip designed for testing urine has been evaluated as a rapid bedside test for SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. In a pilot study, the reagent strip had a sensitivity, specificity, and negative predictive value of 89, 99, and 98 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/25\">",
"     25",
"    </a>",
"    ]. At a peak sensitivity of 96 percent, the test was 89 percent specific. A subsequent study involving 2123 samples demonstrated a sensitivity of only 45 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These studies have used dipsticks designed for testing urine. An ascitic fluid specific dipstick is in development and will likely provide much better sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/27\">",
"     27",
"    </a>",
"    ]. Ongoing studies will help to clarify the role of this approach, which is potentially attractive since it may reduce the time before initiating appropriate treatment. One practical issue in the United States and other countries is the requirement that bedside laboratory testing complies with hospital accreditation standards.",
"   </p>",
"   <p>",
"    Measurement of ascitic fluid lactoferrin has also been proposed as a marker for SBP. Lactoferrin is an iron-binding protein that is believed to help protect human beings from enteric pathogens and contributes to the antimicrobial effects of neutrophils. Higher levels have been correlated with the presence of SBP. A study involving 148 patients with ascites (with 218 ascitic fluid samples) found a sensitivity and specificity of 96 and 87 percent, respectively, using a cut-off level of 242",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/29\">",
"     29",
"    </a>",
"    ]. Additional validation studies are needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DISTINCTION OF SPONTANEOUS FROM SECONDARY BACTERIAL PERITONITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary bacterial peritonitis is defined as an ascitic fluid infection in which there is a positive ascitic fluid bacterial culture and an ascitic fluid PMN count &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3",
"    </span>",
"    with an evident intraabdominal surgically-treatable source of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distinction of SBP from secondary bacterial peritonitis is based largely upon ascitic fluid analysis (which should show neutrocytic ascites), imaging studies, and the response to treatment (",
"    <a class=\"graphic graphic_algorithm graphicRef75590 \" href=\"UTD.htm?17/33/17951\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]. Proposed laboratory criteria for diagnosis of secondary bacterial peritonitis (sometimes referred to as Runyon's criteria) include at least two of the following: total protein &gt;1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     g/L),",
"    </span>",
"    glucose &lt;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    or LDH &gt;the upper limit of normal for serum [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]. A study that evaluated these criteria in 24 patients with secondary bacterial peritonitis compared with a control population of 106 patients with SBP estimated the sensitivity and specificity were 67 and 96 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/30\">",
"     30",
"    </a>",
"    ]. Fulfillment of the two of the criteria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the presence of a polymicrobial ascitic fluid culture was present in 96 percent of patients.",
"   </p>",
"   <p>",
"    Two varieties of secondary bacterial peritonitis have been reported: perforation peritonitis (eg, perforated peptic ulcer into ascites) and nonperforation peritonitis (eg, perinephric abscess) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20,31,32\">",
"     20,31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distinction of secondary bacterial peritonitis from SBP is crucial because of the importance of appropriate therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mortality of secondary bacterial peritonitis approaches 100 percent if treatment consists only of antibiotics with no surgical intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The mortality is approximately 80 percent if a patient with SBP receives an unnecessary exploratory laparotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fortunately, secondary bacterial peritonitis is unusual; approximately one episode will be encountered for every 20 episodes of SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms of both SBP and surgical peritonitis in the presence of ascites can be surprisingly subtle. Ascites prevents the development of a rigid abdomen by separating the visceral from the parietal peritoneal surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, even with frank perforation of the colon and leakage of tens of grams of fecal material into the peritoneal cavity, a classic surgical abdomen does not develop [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Ascitic fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial pretreatment ascitic fluid analysis can be extremely helpful in determining the degree of suspicion of secondary bacterial peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]. A prospective study has shown that neutrocytic fluid (PMN count &ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    with two or more of the following ascitic fluid findings provides strong evidence of secondary bacterial peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Total protein concentration &gt;1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (10",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"     </li>",
"     <li>",
"      Glucose concentration &lt;50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Lactate dehydrogenase greater than the upper limit of normal for serum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following illustrate the range of findings in the largest series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study these criteria were met in 67 percent of patients with secondary bacterial peritonitis versus only 4 percent of those with SBP [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study showed that an ascitic fluid carcinoembryonic antigen &gt;5",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      or ascitic fluid alkaline phosphatase &gt;240",
"      <span class=\"nowrap\">",
"       units/L",
"      </span>",
"      were 92 percent sensitive and 88 percent specific for detecting gut perforation into ascitic fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third report showed that 4.5 percent of patients with peritonitis in cirrhosis had secondary peritonitis; the above protein, glucose, and LDH criteria were 67 percent sensitive and 90 percent specific in detecting secondary peritonitis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/30\">",
"       30",
"      </a>",
"      ]. These criteria",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      polymicrobial infection were present in 96 percent. Abdominal computed tomographic scan was diagnostic in 85 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A Gram stain demonstrating large numbers of",
"    <strong>",
"     different",
"    </strong>",
"    bacterial forms also provides strong evidence of gut perforation (",
"    <a class=\"graphic graphic_picture graphicRef77736 \" href=\"UTD.htm?29/9/29855\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who meet the criteria for secondary bacterial peritonitis should undergo emergency plain and upright abdominal films and a computed tomographic scan of the abdomen. Emergency laparotomy should be performed if free air or a surgically-treatable source of infection is documented [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Response to treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;If neither a free air nor a surgically-treatable source of infection is documented, emergency laparotomy cannot be justified even if suspicion of secondary bacterial peritonitis persists. Repeat paracentesis after 48 hours of treatment (with coverage of aerobic and anaerobic flora) can be helpful in this setting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the follow-up PMN count is lower than the pretreatment value, and the initial culture grows only one organism, the patient probably has SBP; the second culture will probably be sterile.",
"     </li>",
"     <li>",
"      If the PMN count rises and the initial culture grows multiple organisms (especially if enterococcus or fungi are among the flora), the patient probably has nonperforation secondary peritonitis and warrants abdominal computed tomographic scanning in search for abscesses. Many of these patients will require laparotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"       20",
"      </a>",
"      ]. Survivors of laparotomy for surgical peritonitis in the setting of cirrhosis and ascites have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/30,31\">",
"       30,31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This differential response to therapy assumes that an appropriate antibiotic has been administered. If an empiric antibiotic is chosen that does not penetrate ascitic fluid well or does not cover the flora fully, the response of a patient with SBP can mimic that of secondary bacterial peritonitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Peritonitis developing during antibiotic treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;SBP is so exquisitely sensitive to appropriate treatment that it does not develop in our experience in patients who are receiving broad-spectrum parenteral antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .) Thus, a search for a surgical source should be undertaken if such a patient develops bacterial peritonitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other conditions masquerading as secondary bacterial peritonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally peritoneal carcinomatosis or tuberculous peritonitis can be associated with neutrocytic ascites and an initial ascitic fluid analysis that meets criteria for secondary bacterial peritonitis. There are two clues that the diagnosis may not be surgical peritonitis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A predominance of non-PMNs on the differential white cell count",
"     </li>",
"     <li>",
"      The absence of fever",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, SBP that is detected late may also meet criteria for secondary bacterial peritonitis and may have a slow PMN response to therapy. The monomicrobial nature of the infection and the sterility of the second culture help provide evidence that SBP is the correct diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DISTINCTION FROM ALCOHOLIC HEPATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with alcoholic hepatitis warrants specific comment. These patients regularly develop fever, leukocytosis, and abdominal pain, which can masquerade as SBP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"    </a>",
"    .) Furthermore, they also can develop SBP. An important distinguishing point is that peripheral leukocytosis does not lead to an elevated ascitic fluid PMN count [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12296/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, an elevated ascitic fluid PMN count must be presumed to represent SBP. Empiric antibiotic treatment (for presumed ascitic fluid infection) of patients with alcoholic hepatitis, who have fever",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    peripheral leukocytosis can be discontinued after 48 hours if ascitic fluid, blood, and urine cultures demonstrate no bacterial growth and the ascitic fluid PMN count is",
"    <span class=\"nowrap\">",
"     &lt;250/mm3.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    diagnosis of spontaneous bacterial peritonitis is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3).",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appropriate",
"      handling of the ascitic fluid that is aspirated is essential to optimize the results. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Handling of the ascitic fluid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Analysis of the ascitic fluid consists of routine, optional, and unusual tests (",
"      <a class=\"graphic graphic_table graphicRef62032 \" href=\"UTD.htm?30/11/30907\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The development of ascitic fluid specific dipsticks may dramatically speed the diagnosis of SBP.",
"     </li>",
"     <li>",
"      The distinction of secondary bacterial peritonitis from SBP is crucial because the former usually requires antibiotics and surgical treatment while the latter only requires antibiotics (",
"      <a class=\"graphic graphic_algorithm graphicRef75590 \" href=\"UTD.htm?17/33/17951\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Distinction of spontaneous from secondary bacterial peritonitis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H352185256\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/1\">",
"      Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/2\">",
"      Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009; 49:2087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/3\">",
"      Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med 1986; 146:2259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/4\">",
"      Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004; 40:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/5\">",
"      McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991; 31:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/6\">",
"      Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/7\">",
"      Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/8\">",
"      Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int 2005; 25:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/9\">",
"      Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990; 28:2811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/10\">",
"      Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008; 299:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/11\">",
"      Chinnock B, Fox C, Hendey GW. Gram's stain of peritoneal fluid is rarely helpful in the evaluation of the ascites patient. Ann Emerg Med 2009; 54:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/12\">",
"      Angeloni S, Nicolini G, Merli M, et al. Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. Am J Gastroenterol 2003; 98:1844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/13\">",
"      Runyon BA. The evolution of ascitic fluid analysis in the diagnosis of spontaneous bacterial peritonitis. Am J Gastroenterol 2003; 98:1675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/14\">",
"      Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med 1983; 102:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/15\">",
"      Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/16\">",
"      Ackerman Z. Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications. J Clin Gastroenterol 1996; 22:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/17\">",
"      Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/18\">",
"      Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/19\">",
"      Runyon BA, Hoefs JC. Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis. Hepatology 1985; 5:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/20\">",
"      Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/21\">",
"      Runyon BA. Amylase levels in ascitic fluid. J Clin Gastroenterol 1987; 9:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/22\">",
"      Runyon BA. Ascitic fluid bilirubin concentration as a key to choleperitoneum. J Clin Gastroenterol 1987; 9:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/23\">",
"      Runyon BA, Antillon MR. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection. Hepatology 1991; 13:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/24\">",
"      Albillos A, Cuervas-Mons V, Mill&aacute;n I, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990; 98:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/25\">",
"      Castellote J, L&oacute;pez C, Gornals J, et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 2003; 37:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/26\">",
"      Nousbaum JB, Cadranel JF, Nahon P, et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 2007; 45:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/27\">",
"      Mendler MH, Madrigal E, Ysushima M, et al. Developmental phase of a new point of service test for spontaneous bacterial peritonitis (SBP) using a leukocyte esterase method. Gastroenterology 2008; 134:A792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/28\">",
"      Sapey T, Mena E, Fort E, et al. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol 2005; 20:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/29\">",
"      Parsi MA, Saadeh SN, Zein NN, et al. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology 2008; 135:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/30\">",
"      Soriano G, Castellote J, Alvarez C, et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. J Hepatol 2010; 52:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/31\">",
"      Runyon BA, Hoefs JC. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 1984; 4:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/32\">",
"      Runyon BA. Bacterial peritonitis secondary to a perinephric abscess. Case report and differentiation from spontaneous bacterial peritonitis. Am J Med 1986; 80:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/33\">",
"      Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/34\">",
"      Pinzello G, Simonetti RG, Crax&igrave; A, et al. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983; 3:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/35\">",
"      Wu SS, Lin OS, Chen YY, et al. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol 2001; 34:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12296/abstract/36\">",
"      Antillon MR, Runyon BA. Effect of marked peripheral leukocytosis on the leukocyte count in ascites. Arch Intern Med 1991; 151:509.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1249 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-817E36F31F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12296=[""].join("\n");
var outline_f12_0_12296=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SAFETY OF PARACENTESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ASCITIC FLUID ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Handling of the ascitic fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cell count",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Serum-ascites albumin gradient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ascitic fluid total protein concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ascitic fluid glucose concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ascitic fluid lactate dehydrogenase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ascitic fluid amylase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ascitic fluid bilirubin concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dipstick tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DISTINCTION OF SPONTANEOUS FROM SECONDARY BACTERIAL PERITONITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Ascitic fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Response to treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Peritonitis developing during antibiotic treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other conditions masquerading as secondary bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DISTINCTION FROM ALCOHOLIC HEPATITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H352185256\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1249\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1249|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?17/33/17951\" title=\"algorithm 1\">",
"      Diagnosis neutrocytic ascites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1249|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/9/29855\" title=\"picture 1\">",
"      Mixed flora peritoneal fluid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1249|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/61/18395\" title=\"table 1\">",
"      Signs and symptoms of SBP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/0/21515\" title=\"table 2\">",
"      Indications for paracentesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/11/30907\" title=\"table 3\">",
"      Analysis of ascitic fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/56/18315\" title=\"table 4\">",
"      Serum albumin ascites gradient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/42/21162?source=related_link\">",
"      Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/0/7172?source=related_link\">",
"      Clinical manifestations of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=related_link\">",
"      Pathogenesis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40292?source=related_link\">",
"      Spontaneous bacterial peritonitis variants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24022?source=related_link\">",
"      Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=related_link\">",
"      Treatment and prophylaxis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_0_12297="IgA nephropathy EM";
var content_f12_0_12297=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electron micrograph showing mesangial IgA deposits",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power electron micrograph in IgA nephropathy. The primary finding is electron dense deposits that are limited to the mesangial regions (D). The glomerular basement membrane (GBM) is normal and there are no glomerular capillary wall deposits.",
"    <div class=\"footnotes\">",
"     Endo: endothelial cell nucleus.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12297=[""].join("\n");
var outline_f12_0_12297=null;
var title_f12_0_12298="Cigarette smoking and other risk factors for lung cancer";
var content_f12_0_12298=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cigarette smoking and other risk factors for lung cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12298/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12298/contributors\">",
"     David M Mannino, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12298/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12298/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12298/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/0/12298/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/0/12298/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/0/12298/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung cancer is the most common cancer worldwide, with an estimated 1,600,000 new cases and 1,380,000 deaths in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/1\">",
"     1",
"    </a>",
"    ]. In the United States, there will be an estimated 228,000 new cases of lung cancer and 159,500 deaths in 2013 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/2\">",
"     2",
"    </a>",
"    ]. Lung cancer stands out from most other cancers because of our recognition of the major modifiable risk factor leading to the disease &mdash; exposure to tobacco smoke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/34997?source=see_link\">",
"     \"Patterns of tobacco use\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Not all lung cancer is smoking related, however. Other risk factors include exposure to asbestos, haloethers, polycyclic aromatic hydrocarbons, nickel, and arsenic. Interest has also focused on the potential roles of exposure to environmental tobacco smoke (ie, passive exposure to \"second-hand\" smoke) and to radon. Potential risk factors include dietary factors, genetic factors, and the presence of underlying benign forms of parenchymal lung disease, including chronic obstructive lung disease and pulmonary fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12394?source=see_link\">",
"     \"Lung cancer in never smokers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major risk factors for lung cancer will be reviewed here. Issues specific to lung cancer risk in women or HIV-infected patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10072?source=see_link\">",
"     \"Women and lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506361#H1560506361\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Lung cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SMOKING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking prevalence fell among both men and women from 1975 to 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/3\">",
"     3",
"    </a>",
"    ]. This was accompanied by both a decline in the death rate for lung cancer among men and a leveling off of the death rate for lung cancer among women. Bronchogenic carcinoma is undoubtedly the most preventable of the common forms of cancer because of the indisputable link between cigarette smoking and risk of lung cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cigarettes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility that inhalation of cigarette smoke might be a common cause of lung cancer was first suggested by Adler in 1912 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/4\">",
"     4",
"    </a>",
"    ]. However, it was also noted at the time that a \"nearly complete consensus of opinion\" existed \"that primary malignant neoplasms of the lungs are among the rarest forms of the disease.\" In 1920, lung cancer comprised only 1 percent of all malignancies in the US.",
"   </p>",
"   <p>",
"    The first scientific report associating cigarette smoking with an increased risk of premature death appeared in 1938 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/5\">",
"     5",
"    </a>",
"    ]. It was not until 1950, however, that Doll and Hill clearly demonstrated an epidemiologic association between cigarette smoking and lung cancer mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]; this observation was confirmed shortly thereafter by Wynder and Graham [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Evidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evidence linking cigarette smoking to human lung cancer has included a large volume of both prospective and retrospective epidemiologic research. Well-established criteria, based upon observational evidence, have been described for the attribution of causality to the association between disease and a disease-associated variable. These include [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Consistency",
"     </li>",
"     <li>",
"      Strength",
"     </li>",
"     <li>",
"      Specificity",
"     </li>",
"     <li>",
"      Temporal relationship",
"     </li>",
"     <li>",
"      Coherence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon application of these criteria to an enormous body of observational data, the Surgeon General of the United States definitively concluded in 1964 \"cigarette smoking is the major cause of lung cancer\" [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/11\">",
"     11",
"    </a>",
"    ]. This message was again emphasized 40 years later in a 2004 update on the health effects of cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Until recently, the evidence linking cigarette smoking to lung cancer has been primarily indirect. However, a direct link between tobacco and lung cancer was established, based upon the finding that a specific metabolite of benzo(a)pyrene, a chemical constituent of tobacco smoke, damages three specific loci on the p53 tumor-suppressor gene that are known to be abnormal in approximately 60 percent of cases of primary lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/13\">",
"     13",
"    </a>",
"    ]. Related polycyclic aromatic hydrocarbons found in smoke appear capable of targeting other lung cancer mutational hotspots [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Magnitude",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the relative risk of lung cancer in the long-term smoker compared with the lifetime nonsmoker vary from 10- to 30-fold. The cumulative lung cancer risk among heavy smokers may be as high as 30 percent, compared with a lifetime risk of lung cancer of 1 percent or less in never smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of bronchogenic carcinoma is proportional to the total lifetime consumption of cigarettes. The relative risk increases with both the number of cigarettes smoked per day as well as the lifetime duration of smoking. It has been estimated that a 35 year-old man has a 9 percent likelihood of dying from lung cancer before age 85 if he smokes fewer than 25 cigarettes per day, compared with an 18 percent likelihood if he smokes more than 25 cigarettes per day [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional factors include [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age at onset of smoking",
"     </li>",
"     <li>",
"      Degree of inhalation",
"     </li>",
"     <li>",
"      Tar and nicotine content of the cigarettes",
"     </li>",
"     <li>",
"      Use of unfiltered cigarettes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The age at which an increased risk of lung cancer becomes apparent among smokers is the middle to late forties. Beyond that point, the age-specific relative risk for the development of lung cancer rises steadily in smokers until it peaks at an age in the late seventies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation clearly decreases the risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/15,22,23\">",
"     15,22,23",
"    </a>",
"    ]. Large cohort and case-control studies have attempted to quantify the magnitude of the reduction in risk of lung cancer following cessation of smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Estimates of the extent of risk reduction over time vary from 20 to 90 percent, depending upon the duration of abstinence, with a progressive decline in risk associated with an increasing duration of abstinence.",
"     </li>",
"     <li>",
"      An exception to the above pattern is an apparent increase in lung cancer risk within the first few years of abstinence, thought possibly to reflect the presence of symptoms of illness that led to smoking cessation prior to the diagnosis.",
"     </li>",
"     <li>",
"      The reduction in risk becomes evident within five years of becoming abstinent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Case-control studies show that former smokers who had been abstinent for more than 15 years had an 80 to 90 percent reduction in risk of lung cancer compared to current smokers [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/22,25\">",
"       22,25",
"      </a>",
"      ]. However, lung cancer risk remains higher than that in the never smoker, even after prolonged periods of complete abstinence from smoking. It has been estimated that former smokers continue to have a 10 to 80 percent greater risk than never smokers [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/24\">",
"       24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/11/34997?source=see_link\">",
"       \"Patterns of tobacco use\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Smoking cessation may be beneficial even among patients who have been diagnosed with early or limited-stage lung cancer. In a systematic review with meta-analyses, ongoing smoking by patients with early or limited-stage lung cancer was associated with increased likelihood of all-cause mortality, tumor recurrence, and development of a second primary tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Smoking reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In smokers who are unable to quit, reducing smoking appears to have some affect on reducing lung cancer risk. An observational study from Denmark that included 19,714 adults found that after a mean follow-up of 18 years, smokers who used &ge;15 cigarettes or an equivalent amount of tobacco in another form per day and who continued to smoke but cut back by at least 50 percent reduced their risk of lung cancer by 27 percent (95% CI 2-46%) (",
"    <a class=\"graphic graphic_table graphicRef50077 \" href=\"UTD.htm?13/40/13963\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, encouraging smokers who are unable to quit to decrease their smoking may result in harm reduction, including a decreased risk of lung cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Race",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are ethnic and racial differences in the smoking-related risk of lung cancer. This was illustrated by an observational cohort study that followed 183,813 subjects for eight years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/28\">",
"     28",
"    </a>",
"    ]. Lung cancer was identified in 1979 subjects (1 percent). African Americans and Native Hawaiians were most susceptible to lung cancer when fewer than 30 cigarettes per day were smoked; there was no difference among the ethnic groups when smoking exceeded 30 cigarettes per day.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Beta-carotene supplementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     Beta-carotene",
"    </a>",
"    has been studied as a chemopreventive agent, based upon preclinical and epidemiologic data. However, multiple chemoprevention trials have failed to demonstrate any benefit from beta-carotene supplements and have suggested that this approach may be associated with an increased incidence of lung cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8902?source=see_link&amp;anchor=H5#H5\">",
"     \"Chemoprevention of lung cancer\", section on 'Primary chemoprevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A meta-analysis of chemoprevention trials found that high-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    supplementation significantly increased the incidence of lung cancer in smokers (odds ratio [OR] 1.24, 95% CI 1.10-1.39) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/29\">",
"     29",
"    </a>",
"    ]. Among former smokers, the difference was not statistically significant (OR 1.10, 95% CI 0.84-1.85). The high doses of beta-carotene used in these trials may be also be found in multivitamin formulations used to promote visual health.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Second hand smoke",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intensity of exposure to environmental tobacco smoke (ie, passive or \"second-hand\" exposure) is far less than that which occurs with active smoking. On the other hand, exposure to environmental tobacco smoke usually begins much earlier in life than it does with active smoking, and the duration of exposure to carcinogens occurs over a longer period of time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22505?source=see_link\">",
"     \"Secondhand smoke exposure: Effects in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Epidemiologic studies have now shown that nonsmokers exposed to high levels of environmental tobacco smoke demonstrate an increased risk of lung cancer compared to individuals with lower cumulative exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12394?source=see_link\">",
"     \"Lung cancer in never smokers\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also a dose-response relationship between intensity of exposure and relative risk:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, household exposure to 25 or more smoker-years during childhood and adolescence doubled the risk of lung cancer, whereas exposure to fewer than 25 smoker-years did not increase the risk [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/30\">",
"       30",
"      </a>",
"      ]. It was estimated that 17 percent of lung cancer in never smokers is attributable to high levels of environmental smoke exposure during childhood and adolescence.",
"     </li>",
"     <li>",
"      In another report, which had a population based, case-control design, tobacco use by the spouse was associated with a 30 percent increase in risk of lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/31\">",
"       31",
"      </a>",
"      ]. The risk rose with increasing levels of pack-year exposure from the spouse; 80 or more pack-years of exposure was associated with an 80 percent excess risk of lung cancer.",
"     </li>",
"     <li>",
"      A European case-control study involving 650 patients with lung cancer and 1542 controls found nonsignificant increases in lung cancer rates among persons exposed to environmental tobacco smoke from a spouse or workplace exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/33\">",
"       33",
"      </a>",
"      ]. Weak evidence of a dose-response relationship was noted.",
"     </li>",
"     <li>",
"      Analysis of 37 published studies involving over 4600 patients found an excess risk of lung cancer of 24 percent if an individual lived with a smoker [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/32\">",
"       32",
"      </a>",
"      ]. A significant dose-response relationship with the number of cigarettes smoked by the spouse and the duration of exposure was also documented. However, the",
"      <strong>",
"       absolute",
"      </strong>",
"      risk reduction from eliminating this exposure was small, with approximately 1250 persons required to stop smoking in order to prevent one case of lung cancer. Furthermore, it has been suggested that this analysis overestimated the carcinogenicity of passive smoking because of publication bias [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk for the development of lung cancer in response to environmental tobacco smoke may be influenced by genetics. One study found a significant increase in polymorphisms in the gene glutathione S-transferase M1 among 51 nonsmoking women with exposure to environmental tobacco smoke who developed lung cancer compared with 55 nonsmoking women with lung cancer who had no environmental tobacco smoke exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/35\">",
"     35",
"    </a>",
"    ]. Glutathione S-transferase M1 is believed to play a role in detoxifying carcinogens in tobacco smoke; thus, mutations that decrease its activity could serve to promote tumorigenesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cigars",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigar smoking is associated with an increased risk of lung cancer; however, the risk appears weaker than that with cigarettes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/36-40\">",
"     36-40",
"    </a>",
"    ]. This is best illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an observational cohort study, 17,774 men (1546 cigar-only smokers and 16,228 nonsmokers) were followed for 24 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/36\">",
"       36",
"      </a>",
"      ]. Cigar smoking was associated with a higher risk of lung cancer (relative risk 2.1, 95% CI 1.1-4.1). There was a dose-response effect, with men who smoked five or more cigars per day having the greatest risk.",
"     </li>",
"     <li>",
"      In a similar prospective study, 137,243 men were followed for 12 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/40\">",
"       40",
"      </a>",
"      ]. Men who smoked cigars only had an increased risk of death from lung cancer (relative risk 5.1, 95% CI: 4.0-6.6) compared to nonsmokers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The amount of cigar smoke to which the lungs of cigar smokers are exposed varies widely (according to carboxyhemoglobin levels). This probably reflects differences in the number of cigars smoked, the depth of inhalation, and the degree to which each cigar is smoked to completion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/41\">",
"     41",
"    </a>",
"    ]. For these reasons, a threshold at which cigar smoking begins to increase the risk of lung cancer has not been defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pipes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pipe smoking increases the risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/37-39,42\">",
"     37-39,42",
"    </a>",
"    ]. The increased risk of lung cancer due to pipe smoking is similar to cigar smoking, but less than cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This is best illustrated by an observational cohort study that followed 138,307 men (15,263 pipe-only smokers and 123,044 nonsmokers) for 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/42\">",
"     42",
"    </a>",
"    ]. Current pipe smoking was associated with an increased risk of death from lung cancer (relative risk 5.0, 95% CI 4.2-6.0). The risk of lung cancer correlated with the number of pipes smoked per day, years of smoking, and depth of inhalation. Conversely, the risk of lung cancer decreased after smoking cessation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Marijuana",
"    </span>",
"    &nbsp;&mdash;&nbsp;The carcinogenicity of marijuana smoking is less studied than that of tobacco smoking. Several reports have documented histologic and molecular changes in the bronchial epithelium of marijuana smokers that are similar to the metaplastic premalignant alterations that are seen among tobacco smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. However, an association between marijuana smoking and lung cancer has been difficult to prove because studies were limited by selection bias, small sample size, and failure to adjust for tobacco smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. In addition, the duration from the onset of marijuana smoking to outcome (ie, lung cancer) measurement may have been insufficient for lung cancer to develop because young participants were enrolled in most studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34649?source=see_link\">",
"     \"Pulmonary complications of cocaine abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Users of these drugs are probably at increased risk for lung cancer, although the magnitude of risk has not been well quantified [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. The absolute risk of lung cancer that a given individual accrues likely relates to the magnitude and duration of drug use, the amount of adulterants congested, and whether exposure to concomitant carcinogens (such as tobacco smoke) is present. In a case-control study, the risk of lung cancer increased 8 percent for each joint-year of marijuana smoking after adjusting for cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/49\">",
"     49",
"    </a>",
"    ]. In comparison, the risk of lung cancer increased 7 percent for each pack-year of cigarette smoking after adjusting for marijuana smoking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cocaine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The carcinogenicity of cocaine smoking is less studied than that of tobacco smoking. There is some evidence that cocaine smokers have histologic and molecular changes in the bronchial epithelium that are similar to the metaplastic premalignant alterations seen among tobacco smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/43\">",
"     43",
"    </a>",
"    ]. However, additional research is required further define any relationship between cocaine smoking and lung cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     OCCUPATIONAL AND ENVIRONMENTAL CARCINOGENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous occupational and environmental carcinogens increase the risk of lung cancer. The best known factors are asbestos and radon; other exposures include arsenic, bis-chloromethyl ether, chromium, formaldehyde, ionizing radiation, nickel, polycyclic aromatic hydrocarbons, hard metal dust, and vinyl chloride [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/50-59\">",
"     50-59",
"    </a>",
"    ]. Many of these factors act synergistically with tobacco smoke to produce lung cancer, and are also independent risk factors in nonsmokers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=see_link&amp;anchor=H22#H22\">",
"     \"Second malignancies after treatment of classical Hodgkin lymphoma\", section on 'Lung cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30359?source=see_link&amp;anchor=H949706103#H949706103\">",
"     \"Complications of breast and chest wall irradiation for early stage breast cancer\", section on 'Secondary malignancies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, one study of cancer mortality between 1950 and 1997 in Chile found a risk ratio for lung cancer mortality of between three and four in a region with high concentrations of inorganic arsenic in the drinking water [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/56\">",
"     56",
"    </a>",
"    ]. This finding could not be explained by patterns of tobacco use. Further support for a link between arsenic exposure and lung cancer comes from a Taiwanese study demonstrating a progressive decrease in the mortality rate from lung cancer after elimination of arsenic from a community's water supply [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8730?source=see_link&amp;anchor=H8#H8\">",
"     \"Arsenic exposure and poisoning\", section on 'Chronic toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Asbestos",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asbestos exposure is a risk factor for lung cancer to which there can be occupational or nonoccupational exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Occupational",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although some investigators have questioned the causal relationship between occupational asbestos exposure and bronchogenic carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/60\">",
"     60",
"    </a>",
"    ], most studies have demonstrated a clear association between the two entities. As an example, a Dutch cohort study of 58,279 men, in which 524 cases of lung cancer developed, found that asbestos exposure was associated with a relative risk of lung cancer of 3.5 (95% CI 1.7-7.2) after adjustment for age, smoking habits, and intake of vitamin C,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    , and retinol [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/61\">",
"     61",
"    </a>",
"    ]. The risk of lung cancer associated with asbestos exposure is dose-dependent but varies according to the type of asbestos fiber. In particular, for a given level of exposure, the risk appears to be considerably higher for workers exposed to amphibole fibers than for those exposed to chrysotile fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increased risk of lung cancer associated with asbestos is greatly magnified by coexisting exposure to tobacco smoke. In one report, for example, the risk of dying of lung cancer in asbestos workers increased 16-fold if they smoked more than 20 cigarettes per day and 9-fold if they smoked fewer than 20 cigarettes per day, compared to asbestos workers without a regular smoking history [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16472?source=see_link\">",
"     \"Asbestosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of lung cancer associated with combined exposure to asbestos and cigarette smoke appears to be multiplicative. In the same report noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asbestos exposure in the absence of a smoking history was associated with a six-fold relative risk.",
"     </li>",
"     <li>",
"      Cigarette smoking without a history of asbestos exposure was associated with an 11-fold increase in risk.",
"     </li>",
"     <li>",
"      The relative risk for cigarette smokers with a history of asbestos exposure was 59.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For any given individual, the relative risk depends upon the magnitude of the exposure both to cigarette smoke and to asbestos. Workers with asbestosis are at greater risk, although it is unclear if this is because asbestosis is a marker for heavier exposure or if the inflammatory process is important per se in triggering or promoting carcinogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Nonoccupational",
"    </span>",
"    &nbsp;&mdash;&nbsp;The degree to which low level, nonoccupational asbestos exposure increases the risk of lung cancer is less well defined. However, the potential risk is of great public health concern because of the large number of individuals who work or attend school in buildings that contain asbestos, and the cost and potential hazards of asbestos removal. The United States Environmental Protection Agency (EPA) standards for low-level asbestos exposure are based upon linear extrapolation of data from occupational settings to nonoccupational airborne concentrations that are approximately 100,000-fold less [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16472?source=see_link\">",
"     \"Asbestosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One population study of women who resided in chrysotile mining towns in Quebec found that differences in estimated cumulative lifetime environmental asbestos exposure did not produce significant differences in the incidence of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/65\">",
"     65",
"    </a>",
"    ]. The authors speculated that the EPA model may overestimate the dose-response relationship between low level environmental asbestos exposure and lung cancer, although the study's negative findings might also relate to its potential overestimation of asbestos exposure, the fact that the mined asbestos was predominantly chrysotile, or because mined asbestos particles are larger and less respirable than refined asbestos [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/66\">",
"     66",
"    </a>",
"    ]. However, an Italian study also failed to detect an increased risk of lung cancer among persons who resided near an asbestos cement factory in which refined asbestos was used [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Radon",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been considerable public concern in recent years about the possible risk of lung cancer in the general population associated with exposure to radon. Radon is a gaseous decay product of uranium-238 and radium-226, which is capable of damaging respiratory epithelium via the emission of alpha particles. Underground uranium miners who were occupationally exposed to radon and its decay products have an increased risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/68\">",
"     68",
"    </a>",
"    ], and there is an interactive effect between radon exposure and cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/69,70\">",
"     69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radon is present in soil, rock, and groundwater, and it can accumulate in homes. However, the risk associated with exposure to radon in the home remains uncertain in the face of conflicting data. A 2005 meta-analysis of 13 European case-control studies reported a linear relationship between the amount of radon detected in the home and the risk of developing lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/71\">",
"     71",
"    </a>",
"    ]. The increased risk was small but statistically significant, and the authors estimate that radon exposure could be responsible for up to 2 percent of lung cancer deaths in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1560496527\">",
"    <span class=\"h2\">",
"     Smoke from cooking and heating",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indoor burning of unprocessed biomass fuels (wood, coal) is widely used for cooking and heating in many areas of the world and is associated with significant pollution. Such pollution has been associated with multiple respiratory problems, including particularly an increase in the incidence of lung cancer.",
"   </p>",
"   <p>",
"    The importance of such indoor pollution as a cause of lung cancer is illustrated by a retrospective cohort study of over 27,000 individuals from China [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/72\">",
"     72",
"    </a>",
"    ]. The lifelong burning of bituminous coal, which is associated with smoke, was associated with a significant increase in the incidence of lung cancer compared with those individuals who used anthracite (smokeless) coal (hazard ratio 36 for men, 99 for women). The lifetime risk of developing lung cancer was approximately 20 percent for both men and women who used bituminous coal compared with 0.5 percent for those who used anthracite coal.",
"   </p>",
"   <p>",
"    Other studies have similarly implicated smoke from wood burning as a significant risk factor for the development of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/73-77\">",
"     73-77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H420146182\">",
"    <span class=\"h2\">",
"     Diesel exhaust",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated that exposure to diesel exhaust is associated with an increased risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. This risk is proportional to the extent of exposure, and exists even after adjusting for any confounding due to smoking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1068445986\">",
"    <span class=\"h1\">",
"     GENETIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of genetic factors as a cause of lung cancer is only poorly understood, but increasing evidence suggests that such factors play a role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Familial risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies suggest that first-degree relatives of individuals with lung cancer have an increased risk of developing lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/80-82\">",
"     80-82",
"    </a>",
"    ]. In most studies, this excess risk of lung cancer in close relatives persists after adjustment for age, gender, and smoking habits. A meta-analysis of 28 case-control studies and 17 observational cohort studies revealed an increased lung cancer risk associated with having an affected relative (relative risk 1.8, 95% CI 1.6-2.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/80\">",
"     80",
"    </a>",
"    ]. The risk was greatest in relatives of patients diagnosed with lung cancer at a young age and in those with multiple affected family members. Other studies have found a lesser, but still significant risk for lung cancer in second-degree and third-degree relatives [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/83\">",
"     83",
"    </a>",
"    ]. The increased risk in relatives of patients with early onset lung cancer appears to extend to non-lung malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the molecular basis underlying any familial increase in risk is not well characterized, progress in molecular epidemiology suggests that certain population subsets have a higher risk from certain environmental carcinogens, based upon both genetic and acquired susceptibility factors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/85\">",
"     85",
"    </a>",
"    ]. However, because no single genetic factor is sufficiently predictive, it is not yet possible to assess a given individual's risk on a molecular level [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1068446001\">",
"    <span class=\"h2\">",
"     Specific genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in molecular biology are beginning to identify specific single nucleotide polymorphisms (SNPs) or mutations that influence the risk of lung cancer.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A genome-wide association study in never smokers with lung cancer found that a SNP at chromosome 13q31.3 was associated with an increased risk of non-small cell lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/87\">",
"       87",
"      </a>",
"      ]. This observation was validated in several additional cohorts of nonsmokers with lung cancer. This effect appeared to be mediated through a downregulation of the glypican 5 (GPC5) gene.",
"     </li>",
"     <li>",
"      In another study, carriers of the most common mutation associated with cystic fibrosis (delta F508) had a decreased incidence of lung cancer compared with matched controls [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/88\">",
"       88",
"      </a>",
"      ]. This observation requires validation in an independent cohort.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     INFLAMMATION AND BENIGN LUNG DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various benign lung diseases have been associated with an increased risk of lung cancer, which appears to be mediated through chronic inflammation.",
"   </p>",
"   <p>",
"    The most extensive data come from a pooled analysis from the International Lung Cancer Consortium, which analyzed data from 24,607 cases of lung cancer and 81.829 controls in 17 studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/89\">",
"     89",
"    </a>",
"    ]. The risk of lung cancer was elevated in patients with a history of emphysema (odds ratio [OR] 2.44, 95% CI 1.64-3.62), chronic bronchitis (OR 1.47, 95% CI 1.29-1.68), pneumonia (OR 1.57, 95% CI 1.22-2.01), and tuberculosis (OR 1.48, 95% CI 1.17-1.87). The increases in risk involved all histologic types of lung cancer (adenocarcinoma, squamous cell, small cell), and was similar in never, former, and current smokers (except for chronic bronchitis in nonsmokers).",
"   </p>",
"   <p>",
"    These findings are consistent with other studies that have looked specifically at the risk of lung cancer in individuals with tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/90-95\">",
"     90-95",
"    </a>",
"    ] or obstructive lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/96-99\">",
"     96-99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other less common benign lung diseases may also be associated with an increased risk of lung cancer:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individuals with diffuse pulmonary fibrosis have an eight to 14-fold increased risk for lung cancer, even when age, gender, and smoking history are taken into consideration [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/100,101\">",
"       100,101",
"      </a>",
"      ]. Patients with prior asbestos exposure complicated by interstitial fibrosis (ie, asbestosis) are much more likely to develop lung cancer than patients with asbestos exposure alone [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/64,102\">",
"       64,102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Carriers of an allele for alpha-1 antitrypsin deficiency (usually the S or Z allele) have an approximately two-fold increased risk of lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/97\">",
"       97",
"      </a>",
"      ]. Because of the prevalence of these alleles in this population, an alpha-1 antitrypsin deficiency carrier state was estimated to be a contributory cause in 11 to 12 percent of these lung cancer cases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DIETARY FACTORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Antioxidants",
"    </span>",
"    &nbsp;&mdash;&nbsp;An extensive body of literature suggests that low serum concentrations of certain antioxidant compounds, especially derivatives of vitamins A and E, are associated with the development of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/103,104\">",
"     103,104",
"    </a>",
"    ]. Numerous epidemiologic surveys suggested that high levels of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    in the diet or in the blood were associated with a lower risk of cancer in general and lung cancer in particular [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/105\">",
"     105",
"    </a>",
"    ]. In addition, an increased consumption of fruit, green and yellow vegetables, and possibly some micronutrients may be associated with a substantially lower risk of lung cancer, both among cigarette smokers and nonsmokers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/106-108\">",
"     106-108",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, large chemoprevention trials using supplementation with retinoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    ,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alpha tocopherol have not reduced the incidence of lung cancer and some have shown an increase in lung cancer. The results of these trials are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8902?source=see_link&amp;anchor=H5#H5\">",
"     \"Chemoprevention of lung cancer\", section on 'Primary chemoprevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Flavonoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The flavonoids are plant metabolites that have antioxidant, antiestrogenic, and antiproliferative properties. Sources include citrus fruits, parsley, onions, berries, tea, dark chocolate, and red wine. Observational evidence exists that suggests that flavonoids are protective against the development of lung cancer.",
"   </p>",
"   <p>",
"    A prospective cohort study followed 2590 middle-aged men for a mean duration of 16 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/109\">",
"     109",
"    </a>",
"    ]. Lung cancer was detected in 62 men (2.4 percent), all of whom were current or former smokers. The risk of lung cancer was lower for men in the highest quarter of total flavonoid intake, compared to men in the lowest quarter (adjusted relative risk 0.27, 95% CI 0.11-0.66). Out of five flavonoid subclasses, the flavonols and the flavan-3-ols were most strongly associated with lung cancer risk.",
"   </p>",
"   <p>",
"    In another prospective cohort study, 34,708 postmenopausal women were followed for 18 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/110\">",
"     110",
"    </a>",
"    ]. The risk of lung cancer was smaller for women in the highest quintile of flavanone intake (adjusted hazard ratio 0.68, 95% CI 0.53-0.86) and proanthocyanidin intake (adjusted hazard ratio 0.66, 95% CI 0.49-0.89) than women in the lowest quintile. Flavanones and proanthocyanidins are types of flavonoids. The associations existed only among current and former smokers, not among never smokers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Cruciferous vegetables",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cruciferous vegetables are rich in isothiocyanates which have preventative properties against lung cancer in animals. Human observational studies suggest that vegetable consumption has a protective effect against lung cancer, with the best evidence for green cruciferous vegetables (eg, broccoli, cabbage). This protective effect is not definite, however, in view of the small size of the studies and potential confounding from other dietary sources [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To address these limitations, a multi-national case-control study of 2141 cases and 2168 controls was performed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/111\">",
"     111",
"    </a>",
"    ]. Participants were stratified according to their GSTM1 and GSTT1 status. (GSTM1 and GSTT1 are genes that encode enzymes responsible for eliminating isothiocyanates, the likely preventative compound). Weekly consumption of cruciferous vegetables protected against lung cancer in subjects that were both GSTM1 and GSTT1 null (odd ratio 0.28, 95% CI 0.11-0.67). Subjects that were null for only one of the alleles were also protected against lung cancer, but to a lesser extent. Subjects that had both GSTM1 and GSTT1 were not protected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12084252\">",
"    <span class=\"h2\">",
"     B vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of various B vitamins has been investigated as a potential factor in the development of lung cancer. In the European Prospective Investigation into Cancer and Nutrition (EPIC), serum levels of multiple B vitamins, including pyridoxine (vitamin B6), were compared in the 899 individuals who subsequently developed lung cancer and for whom full information was available [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/112\">",
"     112",
"    </a>",
"    ]. Serum levels at baseline were compared with a matched control group of 1770 individuals. In this cohort, lung cancer developed an average of five years after study enrollment.",
"   </p>",
"   <p>",
"    After accounting for smoking and other known risk factors, increasing levels of serum pyridoxine were associated with a statistically significant, progressive decrease in the risk of lung cancer (odds ratio of fourth versus first quartile 0.44, 95% CI 0.33-0.60). Similar differences were seen in smokers, former smokers, and nonsmokers. However, supplementation with B vitamins has not been shown to decrease the risk of lung cancer in randomized clinical trials, and additional study is required to clarify the role of relative deficiency in pyridoxine and other B vitamins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Phytoestrogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;A possible role for phytoestrogens was suggested in a study of 1674 lung cancer patients and 1735 matched healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/113\">",
"     113",
"    </a>",
"    ]. Increased consumption of phytoestrogens was associated with a decreased incidence of lung cancer in both never smokers and current smokers. These findings are consistent with earlier observations that estrogens may have a protective role [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/114,115\">",
"     114,115",
"    </a>",
"    ]. However, they require confirmation in prospective, longitudinal studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     ENDOCRINE FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of estrogen and progesterone on the risk and natural history of lung cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10072?source=see_link&amp;anchor=H7#H7\">",
"     \"Women and lung cancer\", section on 'Endocrine factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     ONCOGENIC VIRUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A significant role for oncogenic viruses in the etiology of lung cancer has not been proven [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/116\">",
"     116",
"    </a>",
"    ]. A viral etiology for one variety of lung cancer, bronchioloalveolar carcinoma (BAC), has been proposed, based upon similarity to a lesion seen in sheep. However, this has not been definitively linked to BAC in humans. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9946?source=see_link\">",
"     \"Bronchioloalveolar carcinoma, including adenocarcinoma in situ\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subsequently, a potential causal role for human papillomavirus (HPV) in squamous cell carcinoma of the lung has been hypothesized because of the presence of HPV DNA within squamous cell carcinomas of the cervix, anorectum, skin, esophagus, and upper airways [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/117\">",
"     117",
"    </a>",
"    ]. Studies analyzing specimens from patients with NSCLC have yielded mixed results [",
"    <a class=\"abstract\" href=\"UTD.htm?12/0/12298/abstract/118,119\">",
"     118,119",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       \"Patient information: Quitting smoking (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=see_link\">",
"       \"Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2502219\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cigarette smoking is the primary cause of lung cancer in North America and Europe. This causal link is well established, and changes in smoking patterns (increased use in women, decreased smoking in men) have been associated with subsequent changes in the epidemiology of lung cancer. Smoking cessation gradually reduces the risk of lung cancer, although not to baseline levels. Other forms of tobacco smoke, including second hand smoke, are associated with lesser increases in the risk of lung cancer (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Smoking'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of occupational and environmental factors are also associated with an increased incidence of lung cancer. Well identified factors include exposure to asbestos, radon, and smoke from wood burning. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Occupational and environmental carcinogens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Various dietary factors have been studied as protective factors against the subsequent development of lung cancer. These include antioxidants, cruciferous vegetables, and B vitamins. Although there appears to be a link between dietary intake of these factors and a lower incidence of lung cancer, this has not translated into useful strategies for lung cancer chemoprevention. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Dietary factors'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8902?source=see_link\">",
"       \"Chemoprevention of lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Various other pulmonary diseases, including pulmonary fibrosis, obstructive disease, alpha-1 trypsin deficiency, and tuberculosis have been associated with a statistically significant increase in the incidence of lung cancer. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Inflammation and benign lung disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/1\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/2\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/3\">",
"      Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008; 100:1672.",
"     </a>",
"    </li>",
"    <li>",
"     Adler L. Primary malignant growth of the lungs and bronchi, Longmans-Green, New York 1912.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/5\">",
"      Pearl R. TOBACCO SMOKING AND LONGEVITY. Science 1938; 87:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/6\">",
"      DOLL R, HILL AB. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950; 2:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/7\">",
"      DOLL R, HILL AB. The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J 1954; 1:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/8\">",
"      Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/9\">",
"      WYNDER EL, GRAHAM EA. Etiologic factors in bronchiogenic carcinoma with special reference to industrial exposures; report of eight hundred fifty-seven proved cases. AMA Arch Ind Hyg Occup Med 1951; 4:221.",
"     </a>",
"    </li>",
"    <li>",
"     A Report of the Surgeon General. The Health Consequences of Smoking: Cancer. DHHS (PHS) 82-50179. Washington, US Department of Health and Human Services, 1982.",
"    </li>",
"    <li>",
"     U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington: U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1964. PHS Publication No. 1103.",
"    </li>",
"    <li>",
"     The Health Consequences of Smoking: A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Washington, DC 2004. CDC Publication No. 7829.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/13\">",
"      Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996; 274:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/14\">",
"      Smith LE, Denissenko MF, Bennett WP, et al. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 2000; 92:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/15\">",
"      Samet JM. Health benefits of smoking cessation. Clin Chest Med 1991; 12:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/16\">",
"      Samet JM, Wiggins CL, Humble CG, Pathak DR. Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis 1988; 137:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/17\">",
"      Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health 1987; 77:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/18\">",
"      Harris JE, Thun MJ, Mondul AM, Calle EE. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8. BMJ 2004; 328:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/19\">",
"      Loeb LA, Ernster VL, Warner KE, et al. Smoking and lung cancer: an overview. Cancer Res 1984; 44:5940.",
"     </a>",
"    </li>",
"    <li>",
"     Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung: non-small cell lung cancer. In: Cancer: Principles and Practice of Oncology, 4th, DeVita S, Hellman S, Rosenberg SA (Eds), Lippincott, Philadelphia 1993. p.673.",
"    </li>",
"    <li>",
"     Burns DM. Cigarette smoking. In: Comprehensive Textbook of Thoracic Oncology, Aisner J, et al (Eds), Williams and Wilkins, Baltimore 1996. p.51.",
"    </li>",
"    <li>",
"     The Health Benefits of Smoking Cessation: A Report of the Surgeon General. US Dept of Health and Human Services, Washington 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/23\">",
"      Peto J. That lung cancer incidence falls in ex-smokers: misconceptions 2. Br J Cancer 2011; 104:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/24\">",
"      Newcomb PA, Carbone PP. The health consequences of smoking. Cancer. Med Clin North Am 1992; 76:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/25\">",
"      Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000; 321:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/26\">",
"      Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340:b5569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/27\">",
"      Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005; 294:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/28\">",
"      Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 2006; 354:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/29\">",
"      Tanvetyanon T, Bepler G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands. Cancer 2008; 113:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/30\">",
"      Janerich DT, Thompson WD, Varela LR, et al. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med 1990; 323:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/31\">",
"      Fontham ET, Correa P, Reynolds P, et al. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA 1994; 271:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/32\">",
"      Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997; 315:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/33\">",
"      Boffetta P, Agudo A, Ahrens W, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998; 90:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/34\">",
"      Copas JB, Shi JQ. Reanalysis of epidemiological evidence on lung cancer and passive smoking. BMJ 2000; 320:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/35\">",
"      Bennett WP, Alavanja MC, Blomeke B, et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999; 91:2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/36\">",
"      Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/37\">",
"      Boffetta P, Pershagen G, J&ouml;ckel KH, et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst 1999; 91:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/38\">",
"      Wald NJ, Watt HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ 1997; 314:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/39\">",
"      Lubin JH, Richter BS, Blot WJ. Lung cancer risk with cigar and pipe use. J Natl Cancer Inst 1984; 73:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/40\">",
"      Shapiro JA, Jacobs EJ, Thun MJ. Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst 2000; 92:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/41\">",
"      Smith JR, Landaw SA. Smokers' polycythemia. N Engl J Med 1978; 298:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/42\">",
"      Henley SJ, Thun MJ, Chao A, Calle EE. Association between exclusive pipe smoking and mortality from cancer and other diseases. J Natl Cancer Inst 2004; 96:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/43\">",
"      Barsky SH, Roth MD, Kleerup EC, et al. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998; 90:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/44\">",
"      Sarafian TA, Magallanes JA, Shau H, et al. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 1999; 20:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/45\">",
"      Mehra R, Moore BA, Crothers K, et al. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006; 166:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/46\">",
"      Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15:1829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/47\">",
"      Ferguson RP, Hasson J, Walker S. Metastatic lung cancer in a young marijuana smoker. JAMA 1989; 261:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/48\">",
"      Sridhar KS, Raub WA Jr, Weatherby NL, et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs 1994; 26:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/49\">",
"      Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008; 31:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/50\">",
"      Chen CL, Hsu LI, Chiou HY, et al. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 2004; 292:2984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/51\">",
"      Brown SC, Schonbeck MF, McClure D, et al. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case-control study. Am J Epidemiol 2004; 160:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/52\">",
"      Beckett WS. Epidemiology and etiology of lung cancer. Clin Chest Med 1993; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/53\">",
"      Fraumeni JF Jr. Respiratory carcinogenesis: an epidemiologic appraisal. J Natl Cancer Inst 1975; 55:1039.",
"     </a>",
"    </li>",
"    <li>",
"     Fraumani JFJ, Blot WJ. Lung and pleura. In: Cancer Epidemiology and Prevention, Fraumani JFJ, Scottenfeld D (Eds), WB Saunders, Philadelphia 1982. p.564.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/55\">",
"      Coultas DB, Samet JM. Occupational lung cancer. Clin Chest Med 1992; 13:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/56\">",
"      Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007; 99:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/57\">",
"      Sorahan T, Burges DC, Hamilton L, Harrington JM. Lung cancer mortality in nickel/chromium platers, 1946-95. Occup Environ Med 1998; 55:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/58\">",
"      Wild P, Perdrix A, Romazini S, et al. Lung cancer mortality in a site producing hard metals. Occup Environ Med 2000; 57:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/59\">",
"      Coggon D, Harris EC, Poole J, Palmer KT. Extended follow-up of a cohort of british chemical workers exposed to formaldehyde. J Natl Cancer Inst 2003; 95:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/60\">",
"      Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/61\">",
"      van Loon AJ, Kant IJ, Swaen GM, et al. Occupational exposure to carcinogens and risk of lung cancer: results from The Netherlands cohort study. Occup Environ Med 1997; 54:817.",
"     </a>",
"    </li>",
"    <li>",
"     Hughes JM, Weill H. Asbestos and man-made fibers. In: Epidemiology of Lung Cancer, Samet JM (Ed), Marcel Dekker, New York 1994. p.185.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/63\">",
"      Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci 1979; 330:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/64\">",
"      Weiss W. Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 1999; 115:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/65\">",
"      Camus M, Siemiatycki J, Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 1998; 338:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/66\">",
"      Landrigan PJ. Asbestos--still a carcinogen. N Engl J Med 1998; 338:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/67\">",
"      Magnani C, Leporati M. Mortality from lung cancer and population risk attributable to asbestos in an asbestos cement manufacturing town in Italy. Occup Environ Med 1998; 55:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/68\">",
"      Grosche B, Kreuzer M, Kreisheimer M, et al. Lung cancer risk among German male uranium miners: a cohort study, 1946-1998. Br J Cancer 2006; 95:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/69\">",
"      Samet JM. Radon and lung cancer. J Natl Cancer Inst 1989; 81:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/70\">",
"      Field RW, Steck DJ, Smith BJ, et al. Residential radon gas exposure and lung cancer: the Iowa Radon Lung Cancer Study. Am J Epidemiol 2000; 151:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/71\">",
"      Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/72\">",
"      Barone-Adesi F, Chapman RS, Silverman DT, et al. Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study. BMJ 2012; 345:e5414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/73\">",
"      Arrieta O, Martinez-Barrera L, Trevi&ntilde;o S, et al. Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study. J Thorac Oncol 2008; 3:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/74\">",
"      Barcenas CH, Delclos GL, El-Zein R, et al. Wood dust exposure and the association with lung cancer risk. Am J Ind Med 2005; 47:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/75\">",
"      Naeher LP, Brauer M, Lipsett M, et al. Woodsmoke health effects: a review. Inhal Toxicol 2007; 19:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/76\">",
"      Hern&aacute;ndez-Gardu&ntilde;o E, Brauer M, P&eacute;rez-Neria J, Vedal S. Wood smoke exposure and lung adenocarcinoma in non-smoking Mexican women. Int J Tuberc Lung Dis 2004; 8:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/77\">",
"      Kurmi OP, Arya PH, Lam KB, et al. Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis. Eur Respir J 2012; 40:1228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/78\">",
"      Olsson AC, Gustavsson P, Kromhout H, et al. Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med 2011; 183:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/79\">",
"      Silverman DT, Samanic CM, Lubin JH, et al. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst 2012; 104:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/80\">",
"      Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005; 93:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/81\">",
"      Cot&eacute; ML, Kardia SL, Wenzlaff AS, et al. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA 2005; 293:3036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/82\">",
"      Cot&eacute; ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012; 48:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/83\">",
"      Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA 2004; 292:2977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/84\">",
"      Naff JL, Cot&eacute; ML, Wenzlaff AS, Schwartz AG. Racial differences in cancer risk among relatives of patients with early onset lung cancer. Chest 2007; 131:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/85\">",
"      Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996; 88:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/86\">",
"      Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 1991; 266:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/87\">",
"      Li Y, Sheu CC, Ye Y, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010; 11:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/88\">",
"      Li Y, Sun Z, Wu Y, et al. Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer 2010; 70:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/89\">",
"      Brenner DR, Boffetta P, Duell EJ, et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol 2012; 176:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/90\">",
"      Zheng W, Blot WJ, Liao ML, et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 1987; 56:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/91\">",
"      Alavanja MC, Brownson RC, Boice JD Jr, Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992; 136:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/92\">",
"      Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995; 141:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/93\">",
"      Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 2001; 30:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/94\">",
"      Engels EA, Shen M, Chapman RS, et al. Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. Int J Cancer 2009; 124:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/95\">",
"      Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 2011; 6:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/96\">",
"      Turner MC, Chen Y, Krewski D, et al. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/97\">",
"      Yang P, Sun Z, Krowka MJ, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008; 168:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/98\">",
"      Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009; 34:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/99\">",
"      Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 2006; 129:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/100\">",
"      Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/101\">",
"      Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000; 161:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/102\">",
"      Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med 1991; 48:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/103\">",
"      Boone CW, Kelloff GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 1990; 50:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/104\">",
"      Woodson K, Tangrea JA, Barrett MJ, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/105\">",
"      Nowak R. Cancer prevention. Beta-carotene: helpful or harmful? Science 1994; 264:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/106\">",
"      Miller AB, Altenburg HP, Bueno-de-Mesquita B, et al. Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2004; 108:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/107\">",
"      Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/108\">",
"      Smith-Warner SA, Spiegelman D, Yaun SS, et al. Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. Int J Cancer 2003; 107:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/109\">",
"      Mursu J, Nurmi T, Tuomainen TP, et al. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer 2008; 123:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/110\">",
"      Cutler GJ, Nettleton JA, Ross JA, et al. Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer 2008; 123:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/111\">",
"      Brennan P, Hsu CC, Moullan N, et al. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 2005; 366:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/112\">",
"      Johansson M, Relton C, Ueland PM, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010; 303:2377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/113\">",
"      Schabath MB, Hernandez LM, Wu X, et al. Dietary phytoestrogens and lung cancer risk. JAMA 2005; 294:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/114\">",
"      Seow A, Poh WT, Teh M, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002; 97:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/115\">",
"      Schabath MB, Wu X, Vassilopoulou-Sellin R, et al. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004; 10:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/116\">",
"      Brouchet L, Valmary S, Dahan M, et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005; 92:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/117\">",
"      Beutner KR, Tyring S. Human papillomavirus and human disease. Am J Med 1997; 102:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/118\">",
"      Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009; 65:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/0/12298/abstract/119\">",
"      Bohlmeyer T, Le TN, Shroyer AL, et al. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 1998; 18:265.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4640 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-CF9877BBA9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12298=[""].join("\n");
var outline_f12_0_12298=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2502219\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SMOKING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cigarettes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Evidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Magnitude",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Smoking reduction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Race",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Beta-carotene supplementation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Second hand smoke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cigars",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pipes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Marijuana",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cocaine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OCCUPATIONAL AND ENVIRONMENTAL CARCINOGENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Asbestos",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Occupational",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Nonoccupational",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Radon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1560496527\">",
"      Smoke from cooking and heating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H420146182\">",
"      Diesel exhaust",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1068445986\">",
"      GENETIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Familial risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1068446001\">",
"      Specific genes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      INFLAMMATION AND BENIGN LUNG DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DIETARY FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Antioxidants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Flavonoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Cruciferous vegetables",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12084252\">",
"      B vitamins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Phytoestrogens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      ENDOCRINE FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      ONCOGENIC VIRUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2502219\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4640\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4640|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/40/13963\" title=\"table 1\">",
"      Risk after reducing smoking",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8730?source=related_link\">",
"      Arsenic exposure and poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/5/16472?source=related_link\">",
"      Asbestosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9946?source=related_link\">",
"      Bronchioloalveolar carcinoma, including adenocarcinoma in situ",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/44/8902?source=related_link\">",
"      Chemoprevention of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=related_link\">",
"      Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30359?source=related_link\">",
"      Complications of breast and chest wall irradiation for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12394?source=related_link\">",
"      Lung cancer in never smokers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=related_link\">",
"      Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/34997?source=related_link\">",
"      Patterns of tobacco use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34649?source=related_link\">",
"      Pulmonary complications of cocaine abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=related_link\">",
"      Second malignancies after treatment of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22505?source=related_link\">",
"      Secondhand smoke exposure: Effects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10072?source=related_link\">",
"      Women and lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_0_12299="Causes of lactose malabsorption";
var content_f12_0_12299=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of lactose malabsorption",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Racial or ethnic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Developmental",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital lactase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Secondary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacterial overgrowth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infectious enteritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Giardiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Mucosal injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Celiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Inflammatory bowel disease (especially Crohn's disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Drug- or radiation-induced enteritis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12299=[""].join("\n");
var outline_f12_0_12299=null;
var title_f12_0_12300="End inspiratory tail";
var content_f12_0_12300=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flow volume loop in mainstem bronchial obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 179px; height: 173px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Maximum flow-volume curves of patient before insertion of a stent in a narrowed left main bronchus. Both an end-inspiratory tail and a biphasic spirogram are seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12300=[""].join("\n");
var outline_f12_0_12300=null;
var title_f12_0_12301="Physical findings in anemia";
var content_f12_0_12301=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical findings as clues to the etiology of anemia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Finding",
"       </td>",
"       <td class=\"subtitle1\">",
"        Possible etiology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Skin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hyperpigmentation",
"       </td>",
"       <td>",
"        Fanconi anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Petechiae, purpura",
"       </td>",
"       <td>",
"        Autoimmune hemolytic anemia with thrombocytopenia, hemolytic-uremic syndrome, bone marrow aplasia, bone marrow infiltration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Carotenemia",
"       </td>",
"       <td>",
"        Suspect iron deficiency in infants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jaundice",
"       </td>",
"       <td>",
"        Hemolytic anemia, hepatitis, and aplastic anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cavernous hemangioma",
"       </td>",
"       <td>",
"        Microangiopathic hemolytic anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ulcers on lower extremities",
"       </td>",
"       <td>",
"        Sickle cell disease (S and C hemoglobinopathies), thalassemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Facies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Frontal bossing, prominence of the malar and maxillary bones",
"       </td>",
"       <td>",
"        Congenital hemolytic anemias, thalassemia major, severe iron deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Eyes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Microcornea",
"       </td>",
"       <td>",
"        Fanconi anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tortuosity of the conjunctival and retinal vessels",
"       </td>",
"       <td>",
"        Sickle cell disease (S and C hemoglobinopathies)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Microaneurysms of retinal vessels",
"       </td>",
"       <td>",
"        Sickle cell disease (S and C hemoglobinopathies)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cataracts",
"       </td>",
"       <td>",
"        Glucose-6-phosphate dehydrogenase deficiency, galactosemia with hemolytic anemia in newborn period",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vitreous hemorrhages",
"       </td>",
"       <td>",
"        S hemoglobinopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Retinal hemorrhages",
"       </td>",
"       <td>",
"        Chronic, severe anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Edema of the eyelids",
"       </td>",
"       <td>",
"        Infectious mononucleosis, exudative enteropathy with iron deficiency, renal failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blindness",
"       </td>",
"       <td>",
"        Osteopetrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Mouth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Glossitis",
"       </td>",
"       <td>",
"        Vitamin B12 deficiency, iron deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Angular stomatitis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Chest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Unilateral absence of the pectoral muscles",
"       </td>",
"       <td>",
"        Poland's syndrome (increased incidence of leukemia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Shield chest",
"       </td>",
"       <td>",
"        Diamond-Blackfan syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Hands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Triphalangeal thumbs",
"       </td>",
"       <td>",
"        Red cell aplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypoplasia of the thenar eminence",
"       </td>",
"       <td>",
"        Fanconi anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spoon nails",
"       </td>",
"       <td>",
"        Iron deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Spleen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enlargement",
"       </td>",
"       <td>",
"        Congenital hemolytic anemia, leukemia, lymphoma acute infection, portal hypertension",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Oski FA, Brugnara G, Nathan DG. A diagnostic approach to the anemia patient. In: Nathan and Oski's Hematology of Infancy and Childhood. WB Sauders, Philadelphia. 1998. p.378.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12301=[""].join("\n");
var outline_f12_0_12301=null;
var title_f12_0_12302="Drugs for GERD in children";
var content_f12_0_12302=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F55435&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F55435&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs demonstrated to be effective for gastroesophageal reflux disease in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of medication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommended oral dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse effects/precautions*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Useful dose forms for children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Proton pump inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Omeprazole",
"       </td>",
"       <td>",
"        <p>",
"         1.0 mg/kg/day divided into one or two doses daily",
"        </p>",
"        <p>",
"         (Adult dose 20 mg once daily)",
"        </p>",
"       </td>",
"       <td>",
"        Headache, diarrhea, abdominal pain, nausea, rash, constipation, vitamin B12 deficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Capsules can be opened and sprinkled on food",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Esomeprazole",
"       </td>",
"       <td>",
"        <p>",
"         1 month to 1 year (daily):",
"        </p>",
"        <p>",
"         &nbsp; 3 to 5 kg: 2.5 mg",
"        </p>",
"        <p>",
"         &nbsp; 5 to 7.5 kg: 5 mg",
"        </p>",
"        <p>",
"         &nbsp; 7.5 to 12 kg: 10 mg",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         1 to 11 years (daily):",
"        </p>",
"        <p>",
"         &nbsp; weight &lt;20 kg: 10 mg",
"        </p>",
"        <p>",
"         &nbsp; weight &gt;20 kg: 10&nbsp;mg or&nbsp;20 mg",
"        </p>",
"        <p>",
"         &nbsp;",
"        </p>",
"        <p>",
"         Adult dose: 20 or 40 mg daily",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Same as above",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         Indication in infants is for erosive esophagitis.",
"        </p>",
"       </td>",
"       <td>",
"        Available as granules for oral suspension, in 2.5, 5, 10, 20 and 40 mg packets.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Lansoprazole",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         0.75-1.5 mg/kg/day",
"        </p>",
"        <p>",
"         (Adult dose: 15-30 mg once daily)",
"        </p>",
"        <p>",
"         IV dose same as oral dose",
"        </p>",
"       </td>",
"       <td rowspan=\"4\">",
"        Headache, diarrhea, abdominal pain, nausea, elevated transaminase, proteinuria, angina, hypotension",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Granules for oral suspension (Prevacid&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dissolving tablet (Prevacid&reg; Solutab&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Capsules can be opened and sprinkled on food",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Pantoprazole",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         No pediatric dose available",
"        </p>",
"        <p>",
"         (Adult dose: 40 mg once daily)",
"        </p>",
"        <p>",
"         IV dose same as oral dose (adults)",
"        </p>",
"       </td>",
"       <td rowspan=\"2\">",
"        Headache, diarrhea, abdominal pain, nausea",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Oral tablets (Protonix&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rabeprazole",
"       </td>",
"       <td>",
"        <p>",
"         No pediatric dose available",
"        </p>",
"        <p>",
"         (Adult dose: 20 mg once daily)",
"        </p>",
"       </td>",
"       <td>",
"        Similar to other PPIs",
"       </td>",
"       <td>",
"        Oral tablets (AcipHex&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Omeprazole and sodium bicarbonate",
"       </td>",
"       <td>",
"        Similar to omeprazole",
"       </td>",
"       <td>",
"        Similar to other PPIs; also avoid using in patients on sodium restricted diets due to high content of sodium bicarbonate",
"       </td>",
"       <td>",
"        Oral capsules (Zegerid&reg; capsules), which should not be opened; powder for oral suspension (Zegerid&reg; powder), which should be dissolved in water",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Histamine",
"        <sub>",
"         2",
"        </sub>",
"        receptor antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cimetidine",
"       </td>",
"       <td>",
"        <p>",
"         40 mg/kg/day divided into three or four doses daily",
"        </p>",
"        <p>",
"         (Adult dose: 800-1200 mg/dose two to three times daily)",
"        </p>",
"       </td>",
"       <td>",
"        Rash, bradycardia, dizziness, nausea, vomiting, hypotension, gynecomastia, reduces hepatic metabolism of theophylline and other medications, neutropenia, thrombocytopenia, agranulocytosis, doses should be decreased with renal insufficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nizatidine",
"       </td>",
"       <td>",
"        <p>",
"         10 mg/kg/day divided into two doses daily",
"        </p>",
"        <p>",
"         (Adult dose: 150 mg/dose twice daily or 300 mg once daily at bedtime)",
"        </p>",
"       </td>",
"       <td>",
"        Headache, dizziness, constipation, diarrhea, nausea, anemia, urticaria, doses should be decreased with renal insufficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Solution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ranitidine",
"       </td>",
"       <td>",
"        <p>",
"         5 to 10 mg/kg/day divided into three doses daily",
"        </p>",
"        <p>",
"         (Adult dose; 300 mg/dose twice daily)",
"        </p>",
"       </td>",
"       <td>",
"        Headache, dizziness, fatigue, irritability, rash, constipation, diarrhea, thrombocytopenia, elevated transaminases, doses should be decreased with renal insufficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Famotidine",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         1 mg/kg/day divided into two doses daily",
"        </p>",
"        <p>",
"         (Adult dose: 20 mg/dose twice daily)",
"        </p>",
"       </td>",
"       <td rowspan=\"2\">",
"        Headache, dizziness, constipation, diarrhea, nausea, doses should be decreased with renal insufficiency",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Powder for suspension (Pepcid&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chewable tablet (Pepcid AC&reg;)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Prokinetic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Cisapride",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         0.8 mg/kg/day divided into four doses daily",
"        </p>",
"        <p>",
"         (Adult dose: 10-20 mg/dose four times daily)",
"        </p>",
"       </td>",
"       <td>",
"        <span class=\"red\">",
"         Rare cases of serious cardiac arrhythmia (FDA recommends ECG before administration)",
"        </span>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Beware of drug interactions (macrolide antibiotics, imidazoles, protease inhibitors)",
"        </span>",
"       </td>",
"       <td>",
"        Very restricted use in the US",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Do not use in patients with liver, cardiac, orelectrolyte abnormalities (FDA recommends checking K+, Ca++, Mg++ and creatine before administration)",
"        </span>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     QD: once daily; BID: twice daily; TID: three times daily; QID: four times daily; QHS: once at bedtime.",
"     <br>",
"      * See individual drug topics for complete discussion of adverse effects.",
"      <br>",
"       <sup>",
"        &bull;",
"       </sup>",
"       Probable slightly increased risk for community-aquired pneumonia and enteric infections.",
"       <br>",
"        &Delta; Not available in many countries because of safety concerns.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Rudolf CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32 Suppl 2:S1.",
"       </li>",
"       <li>",
"        Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drug 2003; 5:25.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12302=[""].join("\n");
var outline_f12_0_12302=null;
var title_f12_0_12303="Pill esophagitis CPC Endosc";
var content_f12_0_12303=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F76438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F76438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Medication-induced esophagitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy revealed superficial ulcerations with bleeding localized in the proximal esophagus at the level of the aortic arch. The mid and distal esophageal mucosa appeared normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andres Gelrud, MD and Kenneth Falchuk, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_0_12303=[""].join("\n");
var outline_f12_0_12303=null;
